Carcinoma in situ of skin

CD2_INSITU_SKIN_EXALLC

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data
1. Apply sex-specific rule None	-
2. Check conditions not C3_SKIN	-
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — D04 Cause of death: ICD-10 — D04 Cancer registry: Topography ICD-O-3 — C44 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — 2 3 out of 7 registries used, show all original rules.	-
4. Check minimum number of events None	-
5. Include endpoints CD2_INSITU_SKIN_LIP CD2_INSITU_SKIN_EYELID CD2_INSITU_SKIN_EAR CD2_INSITU_SKIN_FACE CD2_INSITU_SKIN_SCALPNECK CD2_INSITU_SKIN_TRUNK CD2_INSITU_SKIN_UPPERLIMB CD2_INSITU_SKIN_LOWERLIMB CD2_INSITU_SKIN_NOS	-
6. Filter based on genotype QC (FinnGen only) None	-

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF9
Parent code in ICD-10: D00-D09
Name in latin: Carcinoma in situ cervicis uteri

NAME	CD2_INSITU_SKIN_EXALLC
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	CD2_INSITU_SKIN_LIP\|CD2_INSITU_SKIN_EYELID\|CD2_INSITU_SKIN_EAR\|CD2_INSITU_SKIN_FACE\|CD2_INSITU_SKIN_SCALPNECK\|CD2_INSITU_SKIN_TRUNK\|CD2_INSITU_SKIN_UPPERLIMB\|CD2_INSITU_SKIN_LOWERLIMB\|CD2_INSITU_SKIN_NOS
PRE_CONDITIONS
CONDITIONS	!C3_SKIN
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	D04
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	D04
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C44
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	2

Similar endpoints

↥

List of similar endpoints to Carcinoma in situ of skin based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Carcinoma in situ of skin

Case counts by codes

↥

FinnGen case counts by registry codes:

No upset plot: script not run.

No upset table: script not run.

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	23551	13334	10135
Only index persons	22087	12633	9454
Unadjusted period prevalence (%)
Whole population	0.34	0.38	0.28
Only index persons	0.42	0.46	0.36
Median age at first event (years)
Whole population	78.17	79.15	76.91
Only index persons	78.09	79.01	76.87

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2819	1475	1344
Unadjusted period prevalence (%)	0.55	0.50	0.59
Median age at first event (years)	74.12	73.66	74.64

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
2396: Matched controls
23959

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

R23.8

ICD-10 Finland

Other and unspecified skin changes

7.7

323.3

883

1695

TQW99

NOMESCO Finland

Other minor procedure on skin

21.6

323.0

536

316

L57.0

ICD-10 Finland

Actinic keratosis

21.9

323.0

1227

1097

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

5375.2

323.0

1015

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

14.0

323.0

802

828

D04.5

ICD-10 Finland

Carcinoma in situ: Skin of trunk

548.2

298.5

291

QXA25

NOMESCO Finland

Destruction of lesion of skin, site unspecified

29.9

269.8

369

145

D04.4

ICD-10 Finland

Carcinoma in situ: Skin of scalp and neck

923.5

258.2

249

ZXC50

NOMESCO Finland

Cryotherapy

23.5

256.5

377

189

D04.7

ICD-10 Finland

Carcinoma in situ: Skin of lower limb, including hip

1362.0

255.8

245

D04.6

ICD-10 Finland

Carcinoma in situ: Skin of upper limb, including shoulder

+∞

250.5

236

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

14.8

245.8

431

349

8720/2-C44.9

ICD-O-3

Melanoma in situ of skin, NOS

+∞

233.2

220

QBA25

NOMESCO Finland

Destruction of lesion of skin of trunk

83.4

215.4

241

D48.5

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Skin

11.5

201.5

397

405

C61

ICD-10 Finland

Malignant neoplasm of prostate

307.6

196.2

197

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

2143.3

194.4

186

QAA25

NOMESCO Finland

Destruction of lesion of head or neck

18.0

161.7

259

160

ZXC15

NOMESCO Finland

Use of photodynamic technique

45.8

153.9

190

D04.2

ICD-10 Finland

Carcinoma in situ: Skin of ear and external auricular canal

1568.2

150.6

145

ZXC20

NOMESCO Finland

Use of chemical agents

20.4

134.9

206

110

S18

ICPC

Laceration/cut

2.9

127.3

1313

7146

115

Kela drug reimbursment

Breast cancer

+∞

125.1

119

D04.9

ICD-10 Finland

Carcinoma in situ: Skin, unspecified

406.8

117.6

117

PJA12

NOMESCO Finland

Sentinel node biopsy

584.9

113.9

112

130

Kela drug reimbursment

Malignant tumour

+∞

111.3

106

D06BB10

ATC

imiquimod; topical

7.9

109.4

265

372

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

70.0

104.6

120

116

Kela drug reimbursment

Prostate cancer

+∞

103.9

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

138.5

99.9

106

L82

ICD-10 Finland

Seborrhoeic keratosis

3.3

99.2

599

2197

QBE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin of trunk

6.8

97.9

261

420

XQ848

NOMESCO Finland

Dermatological photography

12.9

97.0

177

147

8742/2-C44.9

ICD-O-3

Lentigo maligna of skin, NOS

+∞

96.5

H02AB02

ATC

dexamethasone; systemic

16.6

91.1

149

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

88.0

Z2221

NOMESCO Finland

Medical doctor

2.6

86.7

824

3996

WF002

NOMESCO Finland

Radical radiotherapy

69.0

81.0

A04AA02

ATC

granisetron; systemic, transdermal

272.7

77.9

D03.5

ICD-10 Finland

Melanoma in situ of trunk

88.1

76.5

ZQZ00

NOMESCO Finland

Treatment of several skin areas

75.3

70.6

SPAT1153

SPAT

Removal of sutures

2.3

70.6

937

5271

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

352.0

68.9

D03.31

ICD-10 Finland

Melanoma in situ in another or unspecified part of the face

109.0

68.2

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

655.3

65.2

ZXE00

NOMESCO Finland

One hour or less

2.1

63.9

1017

6134

HAB40

NOMESCO Finland

Wedge excision of mammary gland

38.0

63.6

HAC20

NOMESCO Finland

Total mastectomy

222.5

63.4

QDE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in lower limb

8.7

63.2

141

171

QCE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in upper limb

10.2

61.4

125

129

ZXD10

NOMESCO Finland

Scheduled procedure

2.1

60.3

1022

6281

R4110

NOMESCO Finland

Physiotherapy

2.3

59.0

726

3863

L02AE02

ATC

leuprorelin; implant, parenteral

43.6

58.2

L02BG04

ATC

letrozole; oral

45.6

57.9

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

10.7

57.2

113

110

ZXE10

NOMESCO Finland

More than one and less than three hours

2.1

57.1

940

5668

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

9.1

56.7

123

142

D22.5

ICD-10 Finland

Melanocytic naevi of trunk

5.5

55.7

174

338

D03.6

ICD-10 Finland

Melanoma in situ of upper limb, including shoulder

194.5

55.2

D22.9

ICD-10 Finland

Melanocytic naevi, unspecified

6.5

54.8

149

243

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

+∞

52.3

JN4BD

NOMESCO Finland

Extensive body CT

4.0

50.6

218

588

Z3231

NOMESCO Finland

Registered nurse

2.1

50.4

740

4200

127

Kela drug reimbursment

Transplant complication

14.3

50.1

ZZR00

NOMESCO Finland

Flap of skin

20.9

48.9

WX110

NOMESCO Finland

Local anesthesy

1.9

48.8

1468

10883

S21

ICPC

Skin texture symptom/complaint

2.6

48.7

394

1663

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

487.3

48.5

L03AA13

ATC

pegfilgrastim; parenteral

487.3

48.5

D03.7

ICD-10 Finland

Melanoma in situ of lower limb, including hip

170.1

48.0

XQ845

NOMESCO Finland

Dermatoscopy

13.1

47.6

L02BB03

ATC

bicalutamide; oral

476.8

47.5

WF003

NOMESCO Finland

Adjuvant radiotherapy

476.8

47.5

A98

ICPC

Health maint/preventive medicine

2.9

47.3

2234

19815

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

2.1

47.2

632

3430

WX408

NOMESCO Finland

General anesthesy, balanced

2.2

46.6

610

3275

WF049

NOMESCO Finland

Radiotherapy of metastasis

466.4

46.4

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

466.4

46.4

TQW80

NOMESCO Finland

Local dermatologic skincare

6.2

45.2

126

212

S29

ICPC

Skin symptom/complaint other

2.3

45.0

495

2450

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

+∞

44.9

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

54.1

44.7

A03FA01

ATC

metoclopramide; systemic, rectal

2.6

43.5

352

1481

L03AA02

ATC

filgrastim; parenteral

45.1

43.3

XX3DW

NOMESCO Finland

Time consuming IT work

4.0

42.6

183

491

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.3

42.2

449

2178

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

69.8

42.1

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

7.4

42.0

103

145

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

218.7

42.0

HA1AA

NOMESCO Finland

X-ray mammography

5.8

41.9

124

225

YL1BD

NOMESCO Finland

Extensive CT examination of pelvis for dose design of radiotherapy

+∞

40.7

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

208.4

40.0

ZX090

NOMESCO Finland

Other technic of radiotherapy

142.4

39.8

C50.99

ICD-10 Finland

Breast, unspecified

+∞

39.7

D04.8

ICD-10 Finland

Carcinoma in situ: Skin of other sites

+∞

39.7

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

39.7

A04AA01

ATC

ondansetron; systemic, rectal

7.0

39.4

100

148

WX002

NOMESCO Finland

Sedation and analgesia

2.1

39.2

566

3133

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

106.8

38.8

L02BA01

ATC

tamoxifen; oral

106.8

38.8

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

38.7

885

5805

L01BC06

ATC

capecitabine; oral

+∞

37.6

L04AA06

ATC

mycophenolic acid; systemic

9.0

37.6

Y77

ICPC

Malignant neoplasm prostate

83.5

36.9

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

5.5

35.8

109

205

QCA25

NOMESCO Finland

Destruction of lesion of skin of upper limb

23.6

35.8

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

3.4

35.8

182

561

D06BX02

ATC

ingenol mebutate; topical

7.3

35.8

125

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

35.5

D04.0

ICD-10 Finland

Carcinoma in situ: Skin of lip

+∞

35.5

Z94.0

ICD-10 Finland

Kidney transplant status

12.4

35.2

E0000UV

ATC

1.8

35.1

906

6124

PJ5AN

NOMESCO Finland

Localisation of sentinell lymphnode with isotope imaging

+∞

34.4

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

177.4

33.8

QAE99

SPAT

16.7

33.8

JN4AD

NOMESCO Finland

Body CT examination

4.1

33.7

136

344

J01DB01

ATC

cefalexin; oral

1.8

33.3

1827

15371

Z3226

NOMESCO Finland

Physiotherapist

2.0

33.3

481

2642

S82

ICPC

Naevus/mole

2.4

32.8

309

1400

QDA25

NOMESCO Finland

Destruction of lesion of skin of lower limb

24.6

32.7

KAS10

NOMESCO Finland

Allogenic transplantation of kidney from cadaver donor

14.4

32.4

C50.21

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,ductal tumor

+∞

32.4

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.7

32.3

1090

7920

KA2AE

NOMESCO Finland

Ultrasound examination transplanted kidney

20.8

31.8

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

31.3

WB203

NOMESCO Finland

Simple adjuvant hormone therapy of malignancy

+∞

31.3

B01AB05

ATC

enoxaparin; parenteral

1.8

31.2

724

4688

A02BC02

ATC

pantoprazole; systemic

1.7

31.1

1518

12183

XW000

NOMESCO Finland

Bone marrow biopsy

4.2

30.7

122

305

S77

ICPC

Malignant neoplasm of skin

41.7

30.0

C90.0

ICD-10 Finland

Multiple myeloma

306.0

29.9

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

6.4

29.8

129

S08

ICPC

Skin colour change

3.2

29.6

161

522

WX302

NOMESCO Finland

Thoracal epidural anesthesy

5.0

29.3

197

WF004

NOMESCO Finland

Palliative radiotherapy

+∞

29.2

L30.9

ICD-10 Finland

Dermatitis, unspecified

2.0

28.7

432

2394

C54.11

ICD-10 Finland

Adenocarcinoma of the endometrium

+∞

28.2

D04.1

ICD-10 Finland

Carcinoma in situ: Skin of eyelid, including canthus

+∞

28.2

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

28.2

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

3.2

28.0

156

514

ZX120

NOMESCO Finland

Intravenous

2.6

27.8

214

866

WZC30

NOMESCO Finland

Teaching

2.4

27.8

251

1108

KCD02

NOMESCO Finland

Transurethral resection of bladder

15.8

27.7

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

146.7

27.7

NK6AN

NOMESCO Finland

Total body bone isotope imaging

25.7

27.5

YJ2VG

NOMESCO Finland

MRI examination of pelvis with high intensity magnet for dose design of radiotherapy

+∞

27.1

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

27.1

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

27.1

Z51.5

ICD-10 Finland

Palliative care

4.1

27.1

109

276

N02BE01

ATC

paracetamol; systemic, rectal

1.8

26.9

2009

17758

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.2

26.6

312

1557

XKD00

NOMESCO Finland

Uroflowmetry

2.0

26.5

407

2269

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.1

26.4

156

534

D22.6

ICD-10 Finland

Melanocytic naevi of upper limb, including shoulder

11.6

26.4

D22.7

ICD-10 Finland

Melanocytic naevi of lower limb, including hip

7.0

26.3

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

+∞

26.1

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.8

25.9

557

3485

9823/3-C42.1

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of bone marrow

263.3

25.7

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

136.4

25.6

QAA50

NOMESCO Finland

Cryotherapy of skin of head or neck

8.9

25.3

ZX070

NOMESCO Finland

Intensity modified radiotherapy

+∞

25.0

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

25.0

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

25.0

C43.52

ICD-10 Finland

Malignant melanoma on the torso: 'superficial spreading' type

+∞

25.0

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

25.0

THW99

NOMESCO Finland

Other minor procedure in surgery of mammary gland

30.4

25.0

ZXE20

NOMESCO Finland

More than three and less than five hours

2.1

24.7

321

1669

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

14.9

24.7

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

24.0

J01MA02

ATC

ciprofloxacin; systemic

1.6

23.9

917

6726

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

242.2

23.7

C50

ICD-10 Finland

Malignant neoplasm of breast

126.2

23.6

D22

ICD-10 Finland

Melanocytic naevi

4.0

23.6

246

UJF32

NOMESCO Finland

Coloscopy

1.7

23.5

621

4116

ZXA05

NOMESCO Finland

Left side

1.7

23.1

667

4528

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

54.6

23.1

C50.91

ICD-10 Finland

Malignant tumor in another specified localization in ductal mammary gland

+∞

22.9

A04AA55

ATC

palonosetron, combinations; systemic

+∞

22.9

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

22.9

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

65.6

22.8

ZXA00

NOMESCO Finland

Right side

1.6

22.7

709

4909

D05.1

ICD-10 Finland

Intraductal carcinoma in situ

84.2

22.7

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

232.0

22.6

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

232.0

22.6

QXE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in uspecified region

18.1

22.2

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

21.9

8520/3-C50.9

ICD-O-3

Lobular carcinoma, NOS, of breast, NOS

+∞

21.9

153

Kela drug reimbursment

Lenalidomid

+∞

21.9

C50.51

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, ductal tumor

+∞

21.9

DAB00

NOMESCO Finland

Excision of lesion of auricle

12.4

21.8

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

21.6

1041

8000

L04AD01

ATC

ciclosporin; systemic

5.5

21.5

119

B01AB10

ATC

tinzaparin; parenteral

2.9

21.4

136

490

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

19.1

21.3

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.9

21.0

131

467

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

+∞

20.9

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

20.9

QXA50

NOMESCO Finland

Skin cryotherapy, unspecified location

10.2

20.8

TKE00

NOMESCO Finland

Needle biopsy of prostate

3.9

20.6

231

D03.4

ICD-10 Finland

Melanoma in situ of scalp and neck

211.7

20.6

D04

ICD-10 Finland

Carcinoma in situ of skin

111.0

20.6

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

42.0

20.4

D22.3

ICD-10 Finland

Melanocytic naevi of other and unspecified parts of face

5.1

20.3

127

R50.9

ICD-10 Finland

Fever, unspecified

2.0

20.3

290

1562

UKC02

NOMESCO Finland

Cystoscopy

1.8

20.1

394

2373

HA1AT

NOMESCO Finland

Biopsy of mammary glands with ultrasound guidance

19.0

19.9

8720/2-C44.6

ICD-O-3

Melanoma in situ of skin of upper limb and shoulder

+∞

19.8

8380/3-C54.1

ICD-O-3

Endometrioid adenocarcinoma, NOS, of endometrium

+∞

19.8

L04AX04

ATC

lenalidomide; oral

+∞

19.8

8720/2-C44.5

ICD-O-3

Melanoma in situ of skin of trunk

+∞

19.8

D07AB08

ATC

desonide; topical

2.1

19.8

247

1261

X76

ICPC

Malignant neoplasm breast female

105.9

19.6

C44.30

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face without histology

105.9

19.6

KA2AT

NOMESCO Finland

Biopsy of transplanted kidney with ultrasound guidance

17.8

19.5

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.9

19.1

310

1749

XF400

NOMESCO Finland

ECG with 12 standard connections

1.7

18.9

435

2745

TQW40

SPAT

3.4

18.9

276

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.7

18.8

489

3199

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

18.8

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

18.8

C50.90

ICD-10 Finland

Malignant tumor in other or unspecified location in mammary gland without histology

+∞

18.8

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

18.8

J01MA12

ATC

levofloxacin; systemic

1.7

18.6

414

2590

B07.9

ICD-10 Finland

Verruca simplex

3.6

18.3

240

Z71.8

ICD-10 Finland

Other specified counselling

1.7

18.2

469

3057

WX320

NOMESCO Finland

Spinalanesthesy

1.6

18.1

545

3699

L04AA01

ATC

[U] ciclosporin; systemic

5.0

18.0

119

Z2446

NOMESCO Finland

Social worker

2.5

17.9

141

578

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

4.9

17.8

120

N02AX02

ATC

tramadol; systemic, rectal

1.5

17.8

934

7210

PJD64

NOMESCO Finland

Laparoscopic dissection of iliac lymph nodes

+∞

17.7

SPAT1141

SPAT

Excision of skin or mucous membrane lesion

2.7

17.7

124

475

WXQ41

NOMESCO Finland

Photodynamic therapy of head and neck

181.2

17.5

C43.59

ICD-10 Finland

Malignant melanoma of the trunk other or unspecified histology

181.2

17.5

C44.72

ICD-10 Finland

Spinocellular carcinoma of the skin of the lower extremity including the hip

181.2

17.5

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.5

17.4

709

5177

R23.4

ICD-10 Finland

Changes in skin texture

7.5

17.2

HA6AA

NOMESCO Finland

Extra corporeal mammography of operated mammary gland

14.9

17.1

SAA02

NOMESCO Finland

Basic examination of mouth

1.4

17.1

1181

9616

L81.4

ICD-10 Finland

Other melanin hyperpigmentation

7.4

17.0

D23.3

ICD-10 Finland

Benign neoplasm: Skin of other and unspecified parts of face

3.8

16.9

189

WX402

NOMESCO Finland

General anaesthesia

1.9

16.9

258

1421

J01CA04

ATC

amoxicillin; systemic

1.5

16.9

1692

14821

J05AB11

ATC

valaciclovir; oral

1.9

16.7

280

1592

C50.42

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, lobular tumor

+∞

16.7

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

+∞

16.7

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

+∞

16.7

8720/2-C44.7

ICD-O-3

Melanoma in situ of skin of lower limb and hip

+∞

16.7

8140/3-C18.7

ICD-O-3

Adenocarcinoma, NOS, of sigmoid colon

+∞

16.7

HA013

NOMESCO Finland

Radiotherapy after total ablation of mammary gland

+∞

16.7

9732/3-C42.1

ICD-O-3

Plasma cell myeloma of bone marrow

171.1

16.5

ZX080

NOMESCO Finland

Image guided radiotherapy

171.1

16.5

HA1CG

NOMESCO Finland

Extensive MRI examination of mammary gland with high intensity magnet

23.2

16.4

B03XA02

ATC

darbepoetin alfa; parenteral

4.5

16.2

129

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.4

16.1

956

7522

R21

ICD-10 Finland

Rash and other nonspecific skin eruption

2.8

16.1

108

404

ZZA00

NOMESCO Finland

Split skin graft

3.4

16.1

229

A02BC01

ATC

omeprazole; systemic

1.5

15.8

681

5013

SAA01

NOMESCO Finland

Simple examination of mouth

1.4

15.7

1330

11180

S26

ICPC

Fear of cancer of skin

6.5

15.7

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.5

15.6

778

5900

R74.8

ICD-10 Finland

Abnormal levels of other serum enzymes

3.0

15.6

318

QBA50

NOMESCO Finland

Cryotherapy of skin of trunk

26.4

15.6

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

3.2

15.5

263

DAB10

NOMESCO Finland

Partial excision of auricle

160.9

15.5

C18.70

ICD-10 Finland

Malignant tumor of the sigmoid without histology

160.9

15.5

WW500

NOMESCO Finland

Blood transfusion

3.6

15.5

199

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

3.4

15.3

222

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

15.2

482

3299

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.5

15.2

663

4879

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

2.7

15.2

103

389

B01AB04

ATC

dalteparin; parenteral

2.4

15.1

131

564

G04CA02

ATC

tamsulosin; oral

1.5

15.1

576

4118

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.1

15.1

172

845

J05AB01

ATC

aciclovir; systemic

1.6

15.0

424

2820

A06AC01

ATC

ispaghula (psylla seeds); oral

1.5

14.9

590

4251

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

2.5

14.8

114

462

TK800

NOMESCO Finland

Hemodialysis

3.6

14.8

186

329

Kela drug reimbursment

Lenalidomide

+∞

14.6

L02BX02

ATC

degarelix; parenteral

+∞

14.6

C18.20

ICD-10 Finland

Malignant tumor of the ascending colon without histology

+∞

14.6

C50.81

ICD-10 Finland

Overall malignant tumor of the mammary gland, ductal tumor

+∞

14.6

8500/3-C50.2

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-inner quadrant of breast

+∞

14.6

8720/3-C44.9

ICD-O-3

Malignant melanoma, NOS, of skin, NOS

+∞

14.6

A04AD12

ATC

aprepitant; systemic

+∞

14.6

PBL10

NOMESCO Finland

Construction of arteriovenous fistula from radial artery

5.0

14.6

HAB50

NOMESCO Finland

Partial excision of mammary gland with reconstructive operation

80.6

14.6

C44.61

ICD-10 Finland

Basocellular carcinoma of the skin of the upper extremity including the shoulder

80.6

14.6

C44.42

ICD-10 Finland

Spinocellular carcinoma of the skin of the scalp and neck

150.8

14.5

TPH04

NOMESCO Finland

Cathetrisation of vein

1.6

14.4

434

2927

A79

ICPC

Malignancy NOS

36.2

14.4

SDA03

NOMESCO Finland

Demanding parodonthologic therapy

1.5

14.4

642

4741

137

Kela drug reimbursment

Uraemia requiring dialysis

6.6

14.3

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

14.3

467

3214

H02AB06

ATC

prednisolone; systemic

1.4

14.2

1033

8383

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

42.7

14.1

JFB31

NOMESCO Finland

Laparoscopic right hemicolectomy

12.0

14.1

L17

ICPC

Foot/toe symptom/complaint

1.5

14.1

596

4351

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.4

14.1

937

7481

D41.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Kidney

4.5

14.0

111

A12AA04

ATC

calcium carbonate; oral

3.8

13.9

155

R4190

NOMESCO Finland

Nutritional therapy

4.5

13.8

108

R31

ICD-10 Finland

Unspecified haematuria

1.8

13.7

234

1338

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

75.5

13.6

D03.9

ICD-10 Finland

Melanoma in situ, unspecified

75.5

13.6

L02BG06

ATC

exemestane; oral

+∞

13.5

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

13.5

C50.4

ICD-10 Finland

Malignant neoplasm: Upper-outer quadrant of breast

+∞

13.5

C18.01

ICD-10 Finland

Malignant tumor of the caecum invasive carcinoma

+∞

13.5

C82.1

ICD-10 Finland

Follicular lymphoma grade II

+∞

13.5

8312/3-C64.9

ICD-O-3

Renal cell carcinoma, NOS, of kidney, NOS

+∞

13.5

C18.21

ICD-10 Finland

Malignant tumor of the ascending colon invasive carcinoma

+∞

13.5

C43.72

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip: 'superficial spreading' type

+∞

13.5

S54

ICPC

Skin, Repair/fix-suture/cast/prosth device

3.0

13.5

259

M79.6

ICD-10 Finland

Pain in limb

1.4

13.5

783

6082

ZXD20

NOMESCO Finland

Day surgery

1.7

13.4

277

1683

KCD05

NOMESCO Finland

Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)

25.9

13.4

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.4

13.3

1005

8174

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

13.3

655

4925

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.6

13.2

362

2379

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

13.2

231

1332

ZZA50

NOMESCO Finland

Full thickness skin graft

28.5

13.0

EP1AE

NOMESCO Finland

Neck ultrasound examination

2.5

12.9

102

418

I10

ICD-10 Finland

Essential (primary) hypertension

1.4

12.9

1541

13533

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

5.2

12.9

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.4

12.9

811

6379

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

50.3

12.8

C44.62

ICD-10 Finland

Spinocellular carcinoma of the skin of the upper extremity including the shoulder

50.3

12.8

R06AE07

ATC

cetirizine; oral

1.4

12.8

814

6413

A11CC03

ATC

alfacalcidol; systemic

2.9

12.8

260

D07AC01

ATC

betamethasone; topical

1.4

12.8

725

5593

ZX112

NOMESCO Finland

Subcutaneous

7.2

12.8

PG1DE

NOMESCO Finland

Other extensive ultrasound examination of artery

2.3

12.7

119

536

L04AX01

ATC

azathioprine; systemic

2.5

12.6

393

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.9

12.6

203

1140

XQ846

NOMESCO Finland

Digital dermatoscopy and registration of nevi

70.2

12.6

L02BG03

ATC

anastrozole; oral

32.2

12.6

C18.00

ICD-10 Finland

Malignant tumor of the caecum without histology

+∞

12.5

C43.31

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face originating in lentigo maligna

+∞

12.5

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

12.5

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

12.5

D41.4

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Bladder

6.7

12.5

ZXC10

NOMESCO Finland

Use of laser

3.4

12.5

181

WXQ99

NOMESCO Finland

Other light therapy

20.1

12.4

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

130.6

12.4

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

130.6

12.4

ZXA10

NOMESCO Finland

Bilateral

1.5

12.4

467

3310

Z49.1

ICD-10 Finland

Extracorporeal dialysis

4.3

12.4

106

D48.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified

4.2

12.4

111

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.5

12.4

411

D23.9

ICD-10 Finland

Benign neoplasm: Skin, unspecified

4.0

12.2

122

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

2.2

12.2

132

632

I15.1

ICD-10 Finland

Hypertension secondary to other renal disorders

4.6

12.2

JN4CD

NOMESCO Finland

Very extensive body CT

3.6

12.1

148

WW200

NOMESCO Finland

Immunization

3.2

12.1

202

J01FA10

ATC

azithromycin; systemic

1.4

12.0

1024

8457

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

46.9

11.9

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.4

11.8

414

190

Kela drug reimbursment

Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide

6.1

11.8

G04BE03

ATC

sildenafil; oral

9.7

11.7

M04AA01

ATC

allopurinol; systemic

1.6

11.6

341

2277

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.6

11.6

323

2130

PBM10

NOMESCO Finland

Closure of arteriovenous fistula of radial artery

19.0

11.6

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.4

11.6

736

5772

K03.64

ICD-10 Finland

Dental calculus supragingival

1.5

11.5

440

3126

R60.0

ICD-10 Finland

Localized oedema

1.6

11.5

280

1783

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.6

11.5

310

2028

C67.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of bladder

+∞

11.5

163

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

11.5

Z85.3

ICD-10 Finland

Personal history of malignant neoplasm of breast

+∞

11.5

8140/3-C18.2

ICD-O-3

Adenocarcinoma, NOS, of ascending colon

+∞

11.5

Z51.0

ICD-10 Finland

Radiotherapy session

+∞

11.5

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

+∞

11.5

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

11.5

8130/2-C67.9

ICD-O-3

Papillary urothelial carcinoma, non-invasive of bladder, NOS

120.5

11.4

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

120.5

11.4

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.8

11.4

207

1210

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

1.9

11.3

170

931

QAA25

SPAT

15.1

11.3

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.4

11.1

652

5036

R04.0

ICD-10 Finland

Epistaxis

1.8

11.0

188

1077

N02AJ06

ATC

codeine and paracetamol; systemic

1.4

11.0

708

5557

UJF30

NOMESCO Finland

Ileoscopy through colon

1.8

11.0

198

1152

C44.71

ICD-10 Finland

Basocellular carcinoma of the skin of the lower extremity including the hip

43.5

10.9

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.3

10.9

1002

8332

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.5

10.9

349

2381

C07AB07

ATC

bisoprolol; oral

1.3

10.9

1235

10609

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

2.3

10.9

101

454

ZXD05

NOMESCO Finland

Urgent procedure

1.4

10.9

632

4870

C03CA01

ATC

furosemide; systemic

1.4

10.8

833

6736

ZX100

NOMESCO Finland

Oral

4.6

10.8

TQW40

NOMESCO Finland

Remowal of suture of skin

2.0

10.8

133

676

B03XA01

ATC

erythropoietin; parenteral

5.6

10.7

L28

ICPC

Limited function/disability (L)

1.5

10.7

425

3041

KMAK

NOMESCO Finland

1.4

10.7

921

7574

TPH07

NOMESCO Finland

Cathetrisation of artery

1.7

10.7

207

1232

L13

ICPC

Hip symptom/complaint

1.5

10.6

401

2837

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.8

10.5

174

985

K02.1

ICD-10 Finland

Caries of dentine

1.3

10.5

974

8097

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

2.1

10.5

122

604

J02AC01

ATC

fluconazole; systemic

1.4

10.5

679

5325

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.3

10.5

957

7935

EAA30

NOMESCO Finland

Partial excision of lower lip

110.5

10.4

128

Kela drug reimbursment

Cancers of female genital organs

110.5

10.4

C44.50

ICD-10 Finland

Malignant tumor of the skin on the torso without histology

110.5

10.4

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

110.5

10.4

C50.31

ICD-10 Finland

Malignant tumor of the lower inner quadrant of the mammary gland, ductal tumor

+∞

10.4

WD205

NOMESCO Finland

Therapy of methastized malignancy with hormones

+∞

10.4

8742/2-C44.3

ICD-O-3

Lentigo maligna of skin of other and unspecified parts of face

+∞

10.4

HAE20

NOMESCO Finland

Reconstruction of areola and mamilla using graft or flap

+∞

10.4

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

10.4

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

+∞

10.4

C43.61

ICD-10 Finland

Malignant melanoma of the upper extremity including the shoulder originating in lentigo maligna

+∞

10.4

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

+∞

10.4

C43

ICD-10 Finland

Malignant melanoma of skin

+∞

10.4

C44.92

ICD-10 Finland

Unspecified localization of spinocellular carcinoma of the skin

+∞

10.4

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

10.4

C43.51

ICD-10 Finland

Malignant melanoma of the trunk originating in lentigo maligna

+∞

10.4

C25.0

ICD-10 Finland

Malignant neoplasm: Head of pancreas

+∞

10.4

H02AB04

ATC

methylprednisolone; systemic

1.6

10.4

316

2130

H02AB07

ATC

prednisone; oral

1.6

10.3

314

2111

S81.8

ICD-10 Finland

Open wound of other parts of lower leg

2.4

10.3

374

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

10.3

474

3489

R05

ICD-10 Finland

Cough

1.5

10.3

415

2976

U13

ICPC

Bladder symptom/complaint other

2.4

10.3

348

L98.9

ICD-10 Finland

Disorder of skin and subcutaneous tissue, unspecified

3.9

10.3

107

HA4AT

NOMESCO Finland

Labeling mammary gland pathology with ultrasound guidance

8.8

10.3

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

3.4

10.3

143

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

4.3

10.3

ZXC96

NOMESCO Finland

Robot assisted procedure

5.8

10.3

PJA10

NOMESCO Finland

Exploration of lymph nodes

9.6

10.2

XJH00

NOMESCO Finland

Transanal ultrasonography

2.0

10.2

137

720

D22.4

ICD-10 Finland

Melanocytic naevi of scalp and neck

4.6

10.2

Z02.4

ICD-10 Finland

Examination for driving licence

1.4

10.1

622

4830

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

3.1

10.1

172

B05DA

ATC

Isotonic solutions

5.9

10.1

SPAT1325

SPAT

Vaccination

1.3

10.0

865

7100

N40

ICD-10 Finland

Hyperplasia of prostate

1.4

10.0

523

3942

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.1

9.9

107

515

SDA02

NOMESCO Finland

Parodonthologic therapy

1.4

9.9

581

4472

QAB10

NOMESCO Finland

Major dressing of wound of skin of head or neck

7.6

9.9

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

2.6

9.9

273

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

9.9

477

3544

HA6BA

NOMESCO Finland

Breast tomosynthesis specimen

26.1

9.8

C44.52

ICD-10 Finland

Spinocellular carcinoma of the skin on the torso

20.1

9.8

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

2.3

9.8

389

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

8.8

9.8

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.6

9.8

233

1475

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

9.7

334

2310

E000001

ATC

1.5

9.7

387

2766

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

0.4

9.7

956

L56.8

ICD-10 Finland

Other specified acute skin changes due to ultraviolet radiation

13.4

9.7

SPAT1336

SPAT

Request for examination

2.2

9.6

428

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.8

9.6

168

972

Q61.2

ICD-10 Finland

Polycystic kidney, autosomal dominant

7.2

9.5

P01AB01

ATC

metronidazole; oral, rectal

1.3

9.4

738

5952

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

100.4

9.4

C44.20

ICD-10 Finland

Malignant tumor of the skin of the outer ear and of the outer ear canal without histology

100.4

9.4

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

100.4

9.4

D03.30

ICD-10 Finland

Melanoma in situ on the lip

100.4

9.4

ZY010

NOMESCO Finland

Hospital outpatient

2.6

9.4

262

L85.80

ICD-10 Finland

Hudhorn

7.6

9.4

L03

ICPC

Low back symptom/complaint

1.4

9.4

482

3615

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

9.4

322

2228

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.8

9.4

148

825

8070/3-C00.1

ICD-O-3

Squamous cell carcinoma, NOS, of external lower lip

+∞

9.4

8500/3-C50.5

ICD-O-3

Infiltrating duct carcinoma, NOS, of lower-outer quadrant of breast

+∞

9.4

C44.22

ICD-10 Finland

Spinocellular carcinoma of the skin of the outer ear and the outer ear canal

+∞

9.4

8500/2-C50.9

ICD-O-3

Intraductal carcinoma, noninfiltrating, NOS, of breast, NOS

+∞

9.4

D03.2

ICD-10 Finland

Melanoma in situ of ear and external auricular canal

+∞

9.4

C50.20

ICD-10 Finland

Malignant tumor of the upper inner quadrant of the mammary gland,no histological veryfication

+∞

9.4

8140/3-C18.9

ICD-O-3

Adenocarcinoma, NOS, of colon, NOS

+∞

9.4

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

+∞

9.4

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

9.4

L02BB04

ATC

enzalutamide; oral

+∞

9.4

352

Kela drug reimbursment

Abiraterone and enzalutamide

+∞

9.4

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

9.4

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

9.4

M01AH05

ATC

etoricoxib; oral

1.3

9.4

1097

9382

Z01.7

ICD-10 Finland

Laboratory examination

1.6

9.4

229

1459

ZZF00

NOMESCO Finland

Graft of adipose tissue

21.8

9.3

-44

ICPC

Preventive immunization/medic

1.7

9.3

211

1313

N03AX16

ATC

pregabalin; oral

1.4

9.3

478

3590

C08CA01

ATC

amlodipine; oral

1.3

9.3

929

7771

QBE99

SPAT

7.3

9.2

A02BC05

ATC

esomeprazole; systemic

1.3

9.1

840

6931

Z49.0

ICD-10 Finland

Preparatory care for dialysis

4.1

9.1

-1

NOMESCO Finland

1.4

9.1

545

4199

M01AH01

ATC

celecoxib; oral (coxibs)

1.4

9.1

395

2870

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

9.0

645

5118

G03HA01

ATC

cyproterone; systemic

15.6

9.0

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.3

9.0

131

5AB14

NOMESCO Finland

36.8

9.0

Z01.2

ICD-10 Finland

Dental examination

1.3

9.0

705

5677

TPX10

NOMESCO Finland

Implantation of vascular injection port

3.1

8.9

154

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

18.7

8.9

R53

ICD-10 Finland

Malaise and fatigue

1.4

8.9

454

3399

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.8

8.9

159

926

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

24.1

8.9

ZX050

NOMESCO Finland

Stereotactic radiotherapy

24.1

8.9

S97

ICPC

Chronic ulcer skin

1.8

8.9

144

810

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.3

8.8

878

7320

N02AA05

ATC

oxycodone; systemic

1.5

8.8

272

1837

KA1AE

NOMESCO Finland

Kidney ultrasound examination

2.9

8.8

178

GD1AD

NOMESCO Finland

Thorax CT examination

2.3

8.7

364

D07AA02

ATC

hydrocortisone; topical

1.6

8.7

232

1511

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.7

8.7

174

1050

S16

ICPC

Bruise/contusion

2.2

8.7

401

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.4

8.6

297

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

8.6

555

4325

VALMI

NOMESCO Finland

1.4

8.6

401

2952

TKC20

NOMESCO Finland

Catheterisation of bladder

1.7

8.6

161

952

L57

ICD-10 Finland

Skin changes due to chronic exposure to nonionizing radiation

9.0

8.5

H25.1

ICD-10 Finland

Senile nuclear cataract

1.3

8.5

775

6374

WF090

NOMESCO Finland

Profylactic radiotherapy

90.3

8.4

HA1DG

NOMESCO Finland

Very extensive MRI examination of mammary gland with high intensity magnet

90.3

8.4

ZX013

NOMESCO Finland

Radiotherapy with large shaped fields - SSD therapy

90.3

8.4

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

90.3

8.4

C44.02

ICD-10 Finland

Spinocellular carcinoma of the lip skin

90.3

8.4

C44.60

ICD-10 Finland

Malignant tumor of the skin of the upper extremity including the shoulder without histology

90.3

8.4

KC1GB

NOMESCO Finland

Cystography with X-ray

12.8

8.4

TDA10

NOMESCO Finland

Needle biopsy of auricle or external auditory canal

12.8

8.4

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

7.9

8.4

N05AX08

ATC

risperidone; systemic

0.5

8.3

1240

C34.30

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung without histology

+∞

8.3

C50.89

ICD-10 Finland

Overall malignant tumor of the mammary gland, other or undeterminated histology

+∞

8.3

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

+∞

8.3

K62.7

ICD-10 Finland

Radiation proctitis

+∞

8.3

8380/3-C54.9

ICD-O-3

Endometrioid adenocarcinoma, NOS, of corpus uteri

+∞

8.3

1CD02

NOMESCO Finland

+∞

8.3

L01BB05

ATC

fludarabine; systemic

+∞

8.3

8260/3-C64.9

ICD-O-3

Papillary adenocarcinoma, NOS, of kidney, NOS

+∞

8.3

WD225

NOMESCO Finland

Demanding therapy of methastized malignancy with hormones

+∞

8.3

C44.12

ICD-10 Finland

Spinocellular carcinoma of the skin of the eyelids including the corner of the eye

+∞

8.3

D23.1

ICD-10 Finland

Benign neoplasm: Skin of eyelid, including canthus

2.2

8.3

374

R06AX27

ATC

desloratadine; oral

1.4

8.2

405

3013

D23.2

ICD-10 Finland

Benign neoplasm: Skin of ear and external auricular canal

4.2

8.2

D02AX

ATC

Other emollients and protectives

2.4

8.2

267

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.6

8.2

190

1193

B35.1

ICD-10 Finland

Tinea unguium

1.9

8.2

119

647

F16

ICPC

Eyelid symptom/complaint

2.1

8.1

456

D01BA02

ATC

terbinafine; oral; topical

1.4

8.1

512

3973

A08

ICPC

Swelling

2.0

8.1

104

539

196

Kela drug reimbursment

Paricalcitol and cinacalcet

8.1

D02AE01

ATC

carbamide; topical

1.8

8.0

135

771

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

8.0

149

878

QCA50

NOMESCO Finland

Cryotherapy of skin of upper limb

22.1

8.0

J01AA02

ATC

doxycycline; systemic

1.3

8.0

1681

15411

Z48.0

ICD-10 Finland

Attention to surgical dressings and sutures

2.2

8.0

357

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.3

7.9

844

7074

C08CA13

ATC

lercanidipine; oral

1.5

7.9

327

2349

V03AE02

ATC

sevelamer; oral

6.6

7.9

N18.8

ICD-10 Finland

Other chronic renal failure

2.2

7.9

331

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.9

7.9

111

598

D64.9

ICD-10 Finland

Anaemia, unspecified

1.5

7.8

237

1591

R01AD09

ATC

mometasone; nasal

1.3

7.8

776

6442

M01AX05

ATC

glucosamine; oral

1.3

7.8

535

4205

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.4

7.7

321

2310

JFB44

NOMESCO Finland

Laparoscopic left hemicolectomy

45.1

7.7

D07.4

ICD-10 Finland

Carcinoma in situ: Penis

45.1

7.7

C44.21

ICD-10 Finland

Basocellular carcinoma of the skin of the outer ear and the outer ear canal

45.1

7.7

ZX197

NOMESCO Finland

45.1

7.7

R4120

NOMESCO Finland

Occupational therapy

1.8

7.7

130

743

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

2.5

7.7

231

U02

ICPC

Urinary frequency/urgency

1.5

7.7

282

1975

H81

ICPC

Excessive ear wax

1.4

7.7

409

3080

XF600

NOMESCO Finland

Bloodpressure measurement

1.8

7.6

130

748

N05CF01

ATC

zopiclone; oral

1.3

7.6

704

5781

K59.1

ICD-10 Finland

Functional diarrhoea

1.9

7.6

111

607

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

8.0

7.6

Z12.5

ICD-10 Finland

Special screening examination for neoplasm of prostate

4.9

7.6

Z49.2

ICD-10 Finland

Other dialysis

4.9

7.6

212

Kela drug reimbursment

Gout

2.5

7.6

234

CBB30

NOMESCO Finland

Excision of lesion of eyelid

2.2

7.6

312

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.3

7.6

919

7825

Z93.3

ICD-10 Finland

Colostomy status

8.9

7.5

L60.0

ICD-10 Finland

Ingrowing nail

2.1

7.5

407

KE1BE

NOMESCO Finland

Rectal ultrasound examinaiton of prostata

1.7

7.5

161

988

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.3

7.5

306

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.4

7.5

405

3056

J01FF01

ATC

clindamycin; systemic

1.3

7.5

523

4118

M05BX04

ATC

denosumab; parenteral

1.9

7.4

101

536

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

80.3

7.4

N25.8

ICD-10 Finland

Other disorders resulting from impaired renal tubular function

6.5

7.4

Z01.8

ICD-10 Finland

Other specified special examinations

1.4

7.4

429

3280

ZX108

NOMESCO Finland

Inhalation

6.0

7.4

SDA04

NOMESCO Finland

Very demanding parodonthologic therapy

1.4

7.3

373

2786

U76

ICPC

Malignant neoplasm of bladder

+∞

7.3

WF001

NOMESCO Finland

Preoperative radiotherapy

+∞

7.3

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

7.3

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

+∞

7.3

WW300

NOMESCO Finland

Transfer of autologic stem cells

+∞

7.3

I97.2

ICD-10 Finland

Postmastectomy lymphoedema syndrome

+∞

7.3

FM1FN

NOMESCO Finland

Heart function isotope examination

+∞

7.3

1AA09

NOMESCO Finland

+∞

7.3

D03.8

ICD-10 Finland

Melanoma in situ of other sites

+∞

7.3

L02BX03

ATC

abiraterone; oral

+∞

7.3

C44.9

ICD-10 Finland

Malignant neoplasm: Malignant neoplasm of skin, unspecified

+∞

7.3

C22.0

ICD-10 Finland

Malignant neoplasm: Liver cell carcinoma

+∞

7.3

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

7.3

C18.41

ICD-10 Finland

Malignant tumor of the transverse colon invasive carcinoma

+∞

7.3

C91.0

ICD-10 Finland

Acute lymphoblastic leukaemia [ALL]

+∞

7.3

C17.9

ICD-10 Finland

Malignant neoplasm: Small intestine, unspecified

+∞

7.3

C18.31

ICD-10 Finland

Malignant tumor of flexura hepatica invasive carcinoma

+∞

7.3

C32.0

ICD-10 Finland

Malignant neoplasm: Glottis

+∞

7.3

C92.0

ICD-10 Finland

Acute myeloblastic leukaemia [AML]

+∞

7.3

C43.39

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face other or unspecified histology

+∞

7.3

C65

ICD-10 Finland

Malignant neoplasm of renal pelvis

+∞

7.3

C50.50

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, no histological veryfication

+∞

7.3

C18.90

ICD-10 Finland

Malignant tumor in unspecified location in the colon without histology

+∞

7.3

WX892

NOMESCO Finland

Monitored bed care

1.7

7.3

157

966

L14

ICPC

Leg/thigh symptom/complaint

1.6

7.2

168

1057

S19

ICPC

Skin injury other

2.0

7.2

443

M10.9

ICD-10 Finland

Gout, unspecified

1.6

7.2

161

1003

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

30.1

7.1

KA9AE

NOMESCO Finland

Ultrasound examination transplanted kidney

20.1

7.1

L01AA02

ATC

chlorambucil; oral

20.1

7.1

R06.0

ICD-10 Finland

Dyspnoea

1.3

7.1

568

4562

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

2.8

7.1

157

QCE99

SPAT

12.0

7.1

L02AE03

ATC

goserelin; implant

12.0

7.1

B05DB

ATC

Hypertonic solutions

5.3

7.1

XCW99

NOMESCO Finland

Other investigative procedure of eye

1.5

7.0

260

1825

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

2.0

7.0

392

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

7.0

437

3379

HA1TE

NOMESCO Finland

Supplementary or limited ultrasound examination of mammary glands

6.3

6.9

WX100

NOMESCO Finland

Conjunctival surface anesthesia

1.4

6.9

313

2286

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

4.2

6.9

R83

ICPC

Respiratory infection other

1.5

6.9

275

1961

1XC02

NOMESCO Finland

7.5

6.9

KAD00

NOMESCO Finland

Partial nephrectomy

13.8

6.9

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

6.9

410

3144

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.8

6.8

119

690

SDA01

NOMESCO Finland

Simple parodonthologic therapy

1.4

6.8

414

3184

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

8.3

6.8

DHB00

NOMESCO Finland

Excision of lesion of external nose

6.7

6.8

D01AE16

ATC

amorolfine; topical

1.5

6.8

257

1815

D13.1

ICD-10 Finland

Benign neoplasm: Stomach

2.3

6.7

248

A28

ICPC

Limited function/disability NOS

1.4

6.7

408

3138

L72.1

ICD-10 Finland

Trichilemmal cyst

1.8

6.7

115

664

D23

ICD-10 Finland

Other benign neoplasms of skin

3.0

6.7

116

E000007

ATC

1.9

6.7

522

CBA10

NOMESCO Finland

Biopsy of eyelid

4.3

6.7

H04.10

ICD-10 Finland

Dry eye syndrome

1.5

6.7

192

1276

D23.7

ICD-10 Finland

Benign neoplasm: Skin of lower limb, including hip

4.7

6.7

TJA35

NOMESCO Finland

Removal of peritoneal dialysis catheter

7.2

6.7

R05

ICPC

Cough

1.4

6.7

428

3319

NA3SA

NOMESCO Finland

Lumbar spine X-ray examination in standing position

3.9

6.7

SPAT1211

SPAT

Application of soft bandage

1.6

6.7

187

1237

K40.9

ICD-10 Finland

Unilateral or unspecified inguinal hernia, without obstruction or gangrene

1.4

6.7

272

1948

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.6

6.7

156

986

S02.51

ICD-10 Finland

Fracture of tooth, open

1.6

6.6

167

1075

N18.0

ICD-10 Finland

End-stage renal disease

3.0

6.6

123

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

6.6

213

1453

J01FA06

ATC

roxithromycin; oral

1.3

6.6

803

6808

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.3

6.6

556

4492

XF612

NOMESCO Finland

Measurement of central venous pressure

12.3

6.6

D40.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Prostate

3.9

6.6

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.0

6.5

383

L57.8

ICD-10 Finland

Other skin changes due to chronic exposure to nonionizing radiation

6.9

6.5

S99

ICPC

Skin disease other

2.5

6.5

191

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.6

6.5

143

891

D34

ICD-10 Finland

Benign neoplasm of thyroid gland

5.3

6.5

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

70.0

6.4

C43.60

ICD-10 Finland

Malignant melanoma of the upper extremity including the shoulder without histology

70.0

6.4

PJD44

NOMESCO Finland

Excision of iliac lymph nodes

70.0

6.4

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

70.0

6.4

PJA01

NOMESCO Finland

Laparoscopic sentinel node excision

70.0

6.4

UKC05

NOMESCO Finland

Cystoscopy and bladder biopsy

4.3

6.4

U04

ICPC

Incontinence urine

1.8

6.4

112

652

3AC01

NOMESCO Finland

3.2

6.4

-54

ICPC

Repair/fix-suture/cast/prosth device

2.3

6.4

224

CK2X4

NOMESCO Finland

Optical coherence tomography (OCT) of ocular fundus

1.5

6.4

210

1442

RS221

NOMESCO Finland

3.2

6.3

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.4

6.3

354

2687

JN6AD

NOMESCO Finland

CT of torso and neck

8.2

6.3

WX610

NOMESCO Finland

Patient controlled analgesia

8.2

6.3

TDM10

NOMESCO Finland

Puncture of maxillary antrum

2.1

6.3

299

JAK10

NOMESCO Finland

Laparotomy and insertion of peritoneal dialysis catheter

5.2

6.3

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.6

6.3

172

1128

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

1.7

6.3

136

842

A03CA02

ATC

clidinium and psycholeptics; oral

1.6

6.3

144

906

C44.91

ICD-10 Finland

Unspecified localization of basocellular carcinoma of the skin

18.1

6.3

RD210

NOMESCO Finland

3.1

6.3

100

C50.9

ICD-10 Finland

Malignant neoplasm: Breast, unspecified

+∞

6.2

8441/3-C56.9

ICD-O-3

Serous carcinoma, NOS, of ovary

+∞

6.2

JGB31

NOMESCO Finland

Laparoscopic and perineal excision of rectum

+∞

6.2

C43.30

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face without histology

+∞

6.2

C43.91

ICD-10 Finland

Unspecified localization of malignant melanoma of the skin originating in lentigo maligna

+∞

6.2

C18.29

ICD-10 Finland

Malignant tumor of the ascending colon or other unspecified histology

+∞

6.2

C43.32

ICD-10 Finland

Malignant melanoma of another or unspecified part of the face 'superficial spreading' type

+∞

6.2

C43.71

ICD-10 Finland

Malignant melanoma of the lower extremity including the hip originating in lentigo maligna

+∞

6.2

8742/2-C44.5

ICD-O-3

Lentigo maligna of skin of trunk

+∞

6.2

C18.40

ICD-10 Finland

Malignant tumor of the transverse colon without histology

+∞

6.2

C83.80

ICD-10 Finland

B-cell lymphoma in marginal zone

+∞

6.2

C82.9

ICD-10 Finland

Follicular lymphoma, unspecified

+∞

6.2

C50.80

ICD-10 Finland

Overall malignant tumor of the mammary gland, no histological veryfication

+∞

6.2

C34.9

ICD-10 Finland

Malignant neoplasm: Bronchus or lung, unspecified

+∞

6.2

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

+∞

6.2

HAC15

NOMESCO Finland

Subcutaneous mastectomy with excision of mamilla

+∞

6.2

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

6.2

9680/3-C77.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of lymph node, NOS

+∞

6.2

8140/3-C34.9

ICD-O-3

Adenocarcinoma, NOS, of lung, NOS

+∞

6.2

C77.2

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes

+∞

6.2

C34.90

ICD-10 Finland

Malignant tumor in unspecified location in bronchus and lung without histology

+∞

6.2

WC305

NOMESCO Finland

Simple therapy of local tumor recidive with biomodifiers

+∞

6.2

C25.9

ICD-10 Finland

Malignant neoplasm: Pancreas, unspecified

+∞

6.2

C81.1

ICD-10 Finland

Nodular sclerosis classical Hodgkin lymphoma

+∞

6.2

C44.3

ICD-10 Finland

Malignant neoplasm: Skin of other and unspecified parts of face

+∞

6.2

C43.7

ICD-10 Finland

Malignant neoplasm: Malignant melanoma of lower limb, including hip

+∞

6.2

C56.71

ICD-10 Finland

Serous epithelial malignant tumor of the ovary

+∞

6.2

C50.59

ICD-10 Finland

Malignant tumor of the lower outer quadrant of the mammary gland, other or undeterminated histology

+∞

6.2

C43.50

ICD-10 Finland

Malignant melanoma of the torso without histology

+∞

6.2

17402

ICD-8 Finland

Malignant neoplasm of breast, Glandulae

+∞

6.2

K52.0

ICD-10 Finland

Gastroenteritis and colitis due to radiation

26.7

6.2

Z45.0

ICD-10 Finland

Adjustment and management of cardiac devices

1.7

6.2

117

695

I78.1

ICD-10 Finland

Naevus, non-neoplastic

2.3

6.2

220

S80

ICPC

Solar keratosis/sunburn

7.0

6.2

B29

ICPC

Lymph/immune mech sympt/complt other

7.0

6.2

XX2AT

NOMESCO Finland

Other injection with ultrasound examination

7.0

6.2

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.8

6.2

543

D16

ICPC

Rectal bleeding

2.5

6.2

183

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.5

6.2

R03AK07

ATC

formoterol and budesonide; inhalant

1.4

6.2

322

2415

K05.30

ICD-10 Finland

Periodontitis complex

1.5

6.2

223

1561

F29

ICPC

Eye symptom/complaint other

1.6

6.1

151

968

A97

ICPC

No disease

1.4

6.1

293

2160

PJD42

NOMESCO Finland

Excision of axillary lymph nodes

7.7

6.1

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.4

6.1

357

2725

WW200

SPAT

0.6

6.1

1215

HAB99

NOMESCO Finland

Other partial excision of mammary gland

4.0

6.1

D06BX01

ATC

metronidazole; topical

1.5

6.1

182

1223

R11

ICD-10 Finland

Nausea and vomiting

1.6

6.1

153

984

R03AC02

ATC

salbutamol; inhalant

1.2

6.1

1002

8785

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

2.1

6.1

316

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.7

6.1

112

662

V03AE03

ATC

lanthanum carbonate; oral

8.6

6.0

D06

ICPC

Abdominal pain localized other

1.6

6.0

137

860

U01

ICPC

Dysuria/painful urination

1.6

6.0

140

884

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(40768804) Tissue Pathology biopsy report

2113

6621

9.75

307.65

2.9

1.7

—

(3002256) Pathology report gross observation

758

1514

6.48

307.65

1.4

1.1

—

(4035726)

393

602

7.42

250.53

1.4

1.2

—

(40768443) Skin Pathology biopsy report

388

901

4.83

156.94

1.2

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

1745

11868

2.23

89.83

10.9

5.9

e9/l

4.2

4.4

2.71

1499

10097

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

386

1358

3.13

83.61

3.7

1.4

ug/l

28.3

3.7

1.09

303

1024

(3018095) Leukocytes [#/volume] in Urine

1320

8254

2.13

81.47

5.5

3.6

e6/l

100.9

118.2

0.44

975

5849

(3022096) Basophils/100 leukocytes in Blood

1473

9625

2.11

80.62

8.2

5.4

0.6

0.7

1.82

1364

8786

(42870588) Differential panel, method unspecified - Blood

1200

7267

2.13

80.23

7.6

5.1

—

(3006504) Eosinophils/100 leukocytes in Blood

1500

9907

2.10

79.32

8.3

5.4

2.8

3.0

2.23

1383

9026

(3030467) Casts [#/volume] in Urine by Automated count

1110

6552

2.14

79.05

4.7

3.0

e6/l

0.5

0.12

874

4933

(3001604) Monocytes [#/volume] in Blood

1582

10667

2.10

79.02

7.6

5.1

e9/l

0.6

0.08

1330

9025

(3002582) Erythrocytes [#/volume] in Urine

1176

7108

2.12

78.60

4.8

3.1

e6/l

44.7

82.4

1.85

935

5428

(3033658) Prothrombin time (PT) actual/Normal

939

5205

2.21

78.37

5.1

3.4

83.3

83.8

0.23

921

5063

(3006315) Basophils [#/volume] in Blood

1588

10748

2.09

78.20

7.6

5.1

e9/l

0.0

0.93

1337

9104

(3019069) Monocytes/100 leukocytes in Blood

1501

9957

2.09

77.95

8.6

5.7

9.0

8.9

1.05

1394

9105

(3019198) Lymphocytes [#/volume] in Blood

1601

10928

2.08

76.32

7.7

5.2

e9/l

2.0

1.8

0.79

1363

9404

(3021589) Normoblasts [#/volume] in Blood

1435

9432

2.06

75.61

13.5

8.9

e9/l

0.0

0.33

1166

7651

(3002030) Lymphocytes/100 leukocytes in Blood

1512

10129

2.06

75.60

8.4

5.5

26.0

26.3

0.38

1398

9203

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

2220

17215

2.36

75.59

9.7

5.3

u/l

81.8

77.2

2.86

2068

15778

(3013115) Eosinophils [#/volume] in Blood

1614

11103

2.06

74.64

7.9

5.2

e9/l

0.2

2.71

1380

9547

(3018010) Neutrophils/100 leukocytes in Blood

1496

10037

2.05

73.85

8.0

5.3

58.7

58.5

0.25

1384

9181

(3024561) Albumin [Mass/volume] in Serum or Plasma

1491

10076

2.02

71.16

6.0

3.6

g/l

34.4

35.0

3.68

1360

9146

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1721

12256

2.04

70.62

8.6

5.4

mmol/l

1.2

0.47

1455

10243

(36304419) Bacteria [Presence] in Urine

1047

6270

2.07

69.69

4.7

3.0

—

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

707

3648

2.25

69.06

3.9

2.9

e6/l

1.8

2.7

2.35

404

1996

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1591

11119

1.99

67.64

7.1

3.7

umol/l

12.4

12.1

0.43

1504

10349

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

535

2481

2.43

66.74

4.6

2.7

u/l

255.5

240.5

1.13

505

2288

(3015377) Calcium [Moles/volume] in Serum or Plasma

1212

7756

1.99

66.05

3.8

2.1

mmol/l

2.4

0.57

1022

6352

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

2479

20631

2.67

64.97

22.2

13.8

ml/min/173m2

69.3

72.1

8.93

2127

16549

(3018418) pH of Serum or Plasma

1129

7089

1.99

64.61

5.8

3.2

7.4

0.24

220

1220

(40758558) Short blood count panel - Blood

865

4947

2.08

64.19

8.0

4.5

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1565

11037

1.94

62.95

7.5

5.0

mmol/l

1.2

0.09

1428

9707

(3010375) cycloSPORINE [Mass/volume] in Blood

11.50

59.63

32.1

24.3

ug/l

99.8

121.4

1.31

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

729

4014

2.10

59.13

3.7

2.7

e6/l

1.0

1.4

1.35

425

2348

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2572

22048

2.90

58.86

23.2

14.8

mg/l

25.8

25.1

0.44

2145

17554

(3002385) Erythrocyte distribution width [Ratio]

2185

17479

2.11

58.83

28.3

17.7

14.0

13.8

9.76

2143

16987

(3031040) Bacteria [#/volume] in Urine by Automated count

2003

15605

1.98

57.04

6.5

5.0

e6/l

3601.3

3625.2

0.00

247

(3023103) Potassium [Moles/volume] in Serum or Plasma

2677

23568

3.70

56.33

27.2

18.4

mmol/l

4.0

0.81

2619

22820

(3019550) Sodium [Moles/volume] in Serum or Plasma

2670

23522

3.56

55.01

26.7

18.3

mmol/l

139.6

139.7

1.99

2614

22819

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2661

23419

3.43

54.45

14.3

9.5

u/l

23.8

24.2

0.48

2554

22204

(3010813) Leukocytes [#/volume] in Blood

2711

24148

4.20

54.10

33.4

21.8

e9/l

6.9

6.8

0.56

2622

23169

(3007461) Platelets [#/volume] in Blood

2710

24136

4.18

54.03

33.4

21.8

e9/l

235.1

241.8

5.72

2627

23281

(3024731) MCV [Entitic volume]

2710

24141

4.17

53.90

33.3

21.7

92.3

91.7

9.34

2663

23593

(3035941) MCH [Entitic mass]

2710

24142

4.17

53.88

33.3

21.7

30.5

30.4

1.55

2663

23596

(3026361) Erythrocytes [#/volume] in Blood

2710

24143

4.17

53.85

33.4

21.8

e12/l

4.3

4.4

11.07

2613

23167

(3000963) Hemoglobin [Mass/volume] in Blood

2710

24148

4.16

53.73

33.6

21.9

g/l

131.3

133.8

13.83

2666

23605

(3000850) Epithelial cells [#/volume] in Urine

840

5054

1.94

52.04

3.7

2.5

e6/l

4.3

5.2

1.62

734

4351

(3044640) Blood type and Crossmatch panel - Blood

1006

6436

1.88

51.55

3.0

2.2

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

604

3282

2.07

49.68

3.5

2.6

21.7

21.8

0.06

539

2706

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

116

254

4.72

49.44

10.2

4.4

iu/ml

985.3

725.2

0.12

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

779

4645

1.94

49.10

3.3

2.3

mmol/l

2.5

1.55

657

3976

(3037467) Urinalysis macro (dipstick) panel - Urine

2015

16076

1.89

48.96

6.2

4.6

—

(3026782) Osmolality of Urine

789

4732

1.93

48.83

4.0

2.7

mosm/kgh2o

544.2

542.6

0.08

690

3926

(3001122) Ferritin [Mass/volume] in Serum or Plasma

1292

9034

1.79

48.75

3.6

2.8

ug/l

142.6

135.7

0.55

1179

8152

(3023368) Bacteria identified in Blood by Culture

1026

6710

1.83

48.26

5.5

3.9

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

632

3524

2.02

48.25

3.3

2.5

g/l

2.2

2.3

1.59

592

3220

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

389

1799

2.35

47.71

2.7

2.1

u/l

31.7

38.0

1.27

329

1499

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

190

5.20

46.05

4.1

2.0

u/ml

91.4

354.9

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

615

3466

1.99

45.21

3.8

2.3

mmol/l

0.8

1.61

558

3146

(3013707) Erythrocyte sedimentation rate by Westergren method

2080

16982

1.86

44.23

5.4

4.2

mm/h

14.8

13.7

2.26

1905

15497

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

792

4922

1.85

42.96

2.8

2.1

—

(3000494) Fungus identified in Specimen by Culture

466

2426

2.10

42.36

1.6

1.4

—

(3022948) Iron [Moles/volume] in Serum or Plasma

653

3853

1.90

41.48

3.4

2.5

umol/l

12.0

12.4

0.56

618

3502

(3027945) Reticulocytes/100 erythrocytes in Blood

552

3079

1.99

41.41

2.8

2.0

1.7

1.8

2.30

496

2677

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

975

6521

1.76

40.93

2.6

2.3

mg/l

3.1

3.0

1.06

835

5504

(3009542) Hematocrit [Volume Fraction] of Blood

2236

18890

1.89

39.94

25.6

16.5

38.8

38.5

0.83

1495

11319

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

425

2184

2.11

39.81

3.3

2.1

umol/l

10.3

8.5

0.60

379

1862

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

2540

22463

2.32

39.76

5.8

5.5

mmol/l

2.5

2.6

9.34

2311

20236

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1320

9648

1.69

39.75

4.8

3.8

—

(3000991) Gas panel - Venous blood

390

1941

2.17

39.66

7.0

6.5

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1774

14048

1.71

39.31

5.4

4.3

mmol/l

6.8

6.9

1.85

1696

13082

(3032080) INR in Blood by Coagulation assay

1382

10280

1.68

38.50

13.1

11.5

inr

1.3

1.4

1.55

378

2774

(3026493) Urate [Moles/volume] in Serum or Plasma

930

6227

1.74

38.33

3.9

2.5

umol/l

5080.6

7320.3

0.68

784

5187

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

13.01

37.46

3.9

1.0

u/ml

22.9

13.5

2.12

(40768795) Lymph node Pathology biopsy report

10.39

36.92

1.2

1.1

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

12.14

35.92

1.2

1.0

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

1472

11278

1.64

35.36

2.3

2.1

pmol/l

95.1

93.9

0.38

734

5625

(3003458) Phosphate [Moles/volume] in Serum or Plasma

523

3028

1.89

34.51

9.5

4.7

mmol/l

1.0

0.51

489

2752

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

2370

20690

1.91

34.35

5.4

4.9

mu/l

2.1

0.09

2141

18478

(40768800) Prostate Pathology biopsy report

147

5.07

34.35

1.3

1.2

—

(40761511) CBC panel - Blood by Automated count

2528

22603

2.15

33.72

20.7

14.7

—

(3020779) Urea [Moles/volume] in Serum or Plasma

395

2096

2.03

33.58

12.0

6.1

mmol/l

11.6

11.5

0.09

381

1960

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

2489

22135

2.06

33.56

5.6

5.2

mmol/l

6.0

6.1

1.20

2228

19686

(3044889) 12 lead EKG panel

1960

16248

1.68

33.54

5.0

4.3

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

2465

21853

2.02

33.43

5.0

4.9

mmol/l

4.4

4.5

6.45

2252

19765

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

2445

21638

1.98

32.98

5.0

4.8

mmol/l

1.5

0.03

2216

19404

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

2420

21429

1.91

31.33

7.1

6.7

mmol/mol

40.3

41.1

4.66

2217

19471

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

1280

9695

1.59

30.59

2.4

2.2

nmol/l

83.0

79.6

4.03

1124

8366

(3020630) Protein [Mass/volume] in Serum or Plasma

391

2138

1.96

30.34

2.5

1.6

g/l

65.1

66.3

2.35

347

1872

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

124

407

3.14

29.65

1.6

1.5

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

652

4198

1.72

29.64

2.1

1.8

—

(3042936) Bacteria identified in Isolate by Culture

522

3161

1.80

29.37

2.1

1.9

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

596

3766

1.74

28.90

2.2

1.9

30.4

29.9

1.06

582

3629

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1344

10405

1.56

28.46

2.5

2.3

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

380

2104

1.93

28.31

5.6

5.4

mmol/l

1.3

1.4

3.01

364

2021

(40768793) Breast Pathology biopsy report

137

4.76

28.06

1.3

1.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

446

2623

1.83

27.48

2.0

1.8

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

2356

20913

1.77

27.23

4.5

4.3

mmol/l

1.3

0.26

2111

18546

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

238

1124

2.22

27.22

4.3

3.6

mmol/l

24.0

24.2

0.34

222

987

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

133

480

2.86

26.91

4.7

2.4

mg/l

2.0

1.8

1.77

121

415

(3005719) IgG [Mass/volume] in Serum or Plasma

270

1356

2.10

26.38

3.7

2.2

g/l

10.3

10.9

1.12

249

1217

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

250

1219

2.15

26.38

1.7

1.5

g/l

1.5

0.13

214

1047

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

14.23

26.22

4.9

3.5

—

(3045142) Bone marrow Pathology biopsy report

166

4.24

26.16

1.2

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1559

12628

1.52

25.79

3.3

2.9

u/l

56.5

49.8

1.51

1413

11323

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

483

2961

1.76

25.76

1.9

1.7

—

(3049717) Cytology report of Urine Cyto stain

186

811

2.38

25.63

2.9

1.8

—

(3026008) Bacteria identified in Urine by Culture

1093

8214

1.54

25.62

4.2

3.5

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

242

1190

2.13

24.96

6.9

7.3

mmol/l

24.3

24.4

0.14

227

1073

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

131

489

2.76

24.89

3.7

1.7

u/ml

3649.5

97.4

1.02

118

385

(3021960) Folate [Moles/volume] in Serum or Plasma

917

6663

1.56

24.85

1.7

1.6

nmol/l

20.9

20.4

0.46

782

5584

(3023520) Reticulocytes [#/volume] in Blood

399

2338

1.82

24.71

3.0

2.1

e9/l

65.5

67.7

0.64

287

1790

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

748

5191

1.60

24.70

4.5

4.2

ng/l

394.0

436.3

0.10

658

4471

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1161

8899

1.52

24.51

3.6

3.2

ng/l

2560.7

1660.2

2.91

1019

7677

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

477

2955

1.74

24.41

2.0

1.8

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

278

1458

2.01

24.08

1.8

1.4

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

867

6276

1.55

23.64

3.5

2.5

u/l

34.4

35.1

0.14

803

5873

(3007164) IgA [Mass/volume] in Serum or Plasma

548

3560

1.67

23.44

1.8

1.3

g/l

2.8

2.7

0.34

304

1929

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1979

17057

1.54

23.08

4.2

3.9

pmol/l

15.0

15.1

1.15

1770

15132

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

307

1698

1.91

22.72

1.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

185

853

2.25

22.38

1.5

1.3

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

289

1576

1.93

22.31

1.8

1.7

—

(3017181) Myelocytes/100 leukocytes in Blood

310

1731

1.89

22.27

5.5

3.5

0.7

0.8

0.39

104

375

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1084

8330

1.49

21.87

5.7

4.1

ug/l

3.1

2.7

0.27

947

7394

(3002179) Metamyelocytes/100 leukocytes in Blood

289

1588

1.91

21.79

5.1

3.4

0.5

0.6

0.19

281

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

669

4642

1.58

21.67

3.6

2.8

ug/l

0.8

0.97

489

3314

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

353

2070

1.81

21.66

4.8

3.4

ng/l

114.5

93.3

2.76

292

1703

(3022145) Colonoscopy Study observation

355

2087

1.80

21.59

1.4

1.3

—

(3021440) Promyelocytes/100 leukocytes in Blood

298

1667

1.88

21.26

5.5

3.5

0.1

0.14

350

(3002032) Base excess in Venous blood by calculation

404

2477

1.74

21.24

4.5

3.3

mmol/l

1.8

2.0

0.58

345

2002

(3021447) Carbon dioxide [Partial pressure] in Venous blood

405

2493

1.73

20.98

4.5

3.3

kpa

5.9

5.8

0.28

395

2404

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

132

539

2.52

20.98

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

132

539

2.52

20.98

1.4

1.3

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

305

1740

1.84

20.42

2.3

1.9

g/l

0.2

2.32

282

1555

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

283

1579

1.88

20.32

1.7

1.4

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

15.09

20.21

3.6

1.9

—

12.6

—

(40768441) Liver Pathology biopsy report

5.57

20.08

1.3

1.2

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

392

2419

1.72

20.07

4.2

3.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

337

2003

1.78

19.68

6.4

3.1

mmol/l

1.2

0.94

294

1683

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

297

2.99

19.51

1.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

212

1088

2.03

19.44

2.2

1.4

g/l

1.0

1.2

2.61

190

970

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

171

811

2.18

19.30

3.1

2.9

u/ml

0.3

1.16

481

(3035350) Ketones [Presence] in Urine by Test strip

1393

11414

1.44

19.27

4.7

4.1

estimate

0.0

0.00

298

1950

(3021601) Nitrite [Presence] in Urine by Test strip

1393

11438

1.43

18.91

6.6

5.4

estimate

0.0

0.00

308

1952

(3052851) Hemolysis interference index of Serum or Plasma

149

679

2.26

18.54

4.1

3.6

—

(3009261) Glucose [Presence] in Urine by Test strip

1403

11582

1.42

18.22

4.7

4.1

estimate

0.0

1.08

304

1898

(46235355) HIV 1 and 2 tests - Meaningful Use set

309

1831

1.77

18.18

1.8

1.5

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

178

879

2.09

18.11

2.0

1.5

g/l

1.1

0.5

0.83

153

736

(3004588) Protein electrophoresis panel - Serum or Plasma

315

1881

1.76

18.04

2.5

1.5

—

(40768806) Pleura Pathology biopsy report

202

3.32

17.78

1.5

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

8.27

17.51

3.3

1.1

u/ml

25.1

19.8

0.41

(3003434) Protein [Mass/volume] in Pleural fluid

294

2.84

16.87

1.4

1.5

g/l

31.0

26.9

1.92

256

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

328

2.74

16.84

3.7

3.4

62.0

59.1

1.17

328

(3025159) Blasts/100 leukocytes in Blood

272

1589

1.79

16.76

5.5

3.6

0.1

0.3

0.36

310

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

815

6166

1.45

16.75

1.6

mmol/l

1.3

0.06

681

5073

(40768797) Stomach Pathology biopsy report

457

3073

1.58

16.47

1.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

157

768

2.11

16.38

1.8

1.5

g/l

0.1

0.0

0.37

141

696

(40768446) Kidney Pathology biopsy report

5.38

16.36

1.8

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

185

962

1.99

16.34

2.5

2.1

nmol/l

13.3

14.7

1.01

154

823

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

331

2.68

16.01

2.3

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

4.52

15.88

1.2

1.1

—

(3003338) MCHC [Mass/volume]

1995

17747

1.42

15.64

30.8

19.9

g/l

330.1

331.4

9.01

1976

17574

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

240

2.97

15.63

3.9

3.8

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

122

3.82

15.38

2.3

1.5

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

147

722

2.09

15.19

1.8

1.5

g/l

0.0

0.00

133

651

(3036489) Thrombin time

139

671

2.13

15.02

2.0

1.8

21.9

21.1

0.69

127

596

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

268

2.81

14.98

1.8

1.2

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

110

483

2.33

14.97

2.8

2.1

g/l

3.6

3.5

0.20

102

458

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

132

626

2.16

14.93

1.8

1.6

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

193

1054

1.89

14.75

1.9

1.5

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

193

1056

1.89

14.67

1.9

1.4

g/l

7.5

0.05

154

755

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

192

1052

1.89

14.53

1.9

1.5

g/l

3.8

0.23

146

731

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

4.25

14.33

2.5

2.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

231

2.90

14.24

1.8

1.2

u/ml

116.9

108.9

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

4.52

14.24

1.7

2.2

—

(40760892) CBC W Ordered Manual Differential panel - Blood

584

4258

1.47

14.21

6.3

4.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

142

708

2.06

14.11

1.8

1.5

g/l

0.0

0.00

130

647

(3028308) Erythrocytes [#/volume] in Pleural fluid

240

2.84

13.86

1.4

1.5

e6/l

27182.8

64720.4

0.68

143

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

103

456

2.31

13.78

2.2

1.4

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

219

2.92

13.77

2.0

1.4

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

159

834

1.96

13.71

1.8

1.4

g/l

36.8

37.3

0.42

139

685

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

181

992

1.88

13.69

1.9

1.5

g/l

9.6

10.4

1.89

159

814

(3042111) Morphology [Interpretation] in Bone marrow Narrative

347

2.49

13.60

1.8

1.3

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

106

478

2.27

13.58

2.1

1.4

—

(3024354) Oxygen [Partial pressure] in Venous blood

324

2099

1.61

13.52

3.5

2.9

kpa

4.5

0.22

316

2013

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

435

2.32

13.48

2.6

2.2

198.1

196.4

0.07

412

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

178

978

1.88

13.36

2.0

1.5

g/l

3.2

3.1

0.33

147

745

(3024891) Influenza virus A+B Ag [Presence] in Specimen

102

456

2.28

13.34

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

263

2.70

13.25

1.5

e6/l

1188.0

2184.8

0.61

190

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

103

472

2.23

12.72

2.3

2.0

91.0

89.2

0.35

451

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

281

2.60

12.66

1.9

1.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

155

830

1.92

12.59

3.5

1.5

ratio

1.5

2.2

0.59

(21494814) CD8 cells/100 lymphocytes in Specimen

5.98

12.59

1.1

2.6

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

159

859

1.90

12.58

3.7

1.6

mg/l

41.1

42.2

0.04

121

707

(3037522) Nuclear Ab [Titer] in Serum

396

2729

1.52

12.58

1.4

1.3

titre

603.6

559.7

0.15

644

(3051651) Icteric interference index of Serum or Plasma

3.91

12.53

4.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

159

861

1.90

12.49

3.6

1.6

mg/l

86.9

46.3

0.73

121

711

(3042733) HLA Ab [Presence] in Serum

6.22

12.47

5.4

3.8

—

(21494434) Karyotype in Bone marrow

193

2.94

12.46

1.2

1.1

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

118

576

2.09

12.43

1.5

1.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

232

2.75

12.42

1.3

1.1

u/ml

282.0

297.0

0.15

139

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

852

6777

1.37

12.36

4.8

4.0

22.7

24.4

2.27

420

3446

(3004809) Band form neutrophils/100 leukocytes in Blood

273

2.60

12.34

5.6

3.0

1.0

1.4

0.51

198

(3012441) Differential panel - Pleural fluid

216

2.82

12.34

1.6

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

4.11

12.30

1.3

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

7.77

12.29

1.2

1.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

292

2.54

12.22

1.9

1.4

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

143

754

1.94

12.17

1.3

1.2

—

(3024928) Oxygen saturation in Venous blood

107

508

2.15

12.12

2.2

2.9

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

631

4789

1.41

12.11

1.8

1.7

mg/l

1.6

1.4

1.12

488

3718

(3000492) Spirometry study

270

1722

1.63

11.98

1.9

1.5

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

6.37

11.55

1.3

2.9

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

326

2.40

11.45

1.3

1.1

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

7.12

11.42

1.2

1.0

—

(3045788) Cell count panel - Pleural fluid

209

2.76

11.35

1.5

1.6

—

(3011412) CD3 cells [#/volume] in Blood

100

3.63

11.33

2.0

e9/l

1.0

0.24

(3003694) ABO and Rh group [Type] in Blood

654

5047

1.39

11.27

1.4

1.3

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

896

7276

1.34

11.11

2.8

2.3

u/l

69.3

59.2

1.21

799

6620

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

420

2.21

11.08

1.4

1.2

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

10.95

11.06

4.0

2.3

—

(3037756) Immunofixation for Serum or Plasma

106

525

2.06

10.78

2.1

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

4.58

10.71

2.3

1.9

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

282

1874

1.56

10.50

2.2

1.8

nmol/l

362.5

371.6

0.28

265

1660

(40761536) Microorganisms panel - Urine sediment

273

1802

1.57

10.47

6.0

4.2

—

(3051611) Lipemic interference index of Serum or Plasma

216

2.62

10.15

4.1

3.7

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

252

2.49

10.10

1.3

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

3.78

10.03

1.3

2.1

20.8

15.3

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

4.63

10.00

2.5

1.3

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

353

2.21

9.58

1.9

1.3

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

102

3.36

9.58

1.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

717

5741

1.33

9.51

4.1

—

(3003396) Base excess in Arterial blood by calculation

401

2921

1.43

9.50

5.9

5.8

mmol/l

0.6

1.4

3.16

320

2233

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

103

3.33

9.44

1.4

1.3

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

103

3.33

9.44

1.4

1.3

—

(3027801) Oxygen [Partial pressure] in Arterial blood

402

2935

1.43

9.40

6.0

5.8

kpa

12.1

11.4

1.64

379

2775

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

402

2936

1.43

9.38

6.0

5.8

kpa

5.0

5.1

1.08

380

2783

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

551

4283

1.36

8.83

1.3

1.2

u/ml

2.1

1.7

0.15

108

1077

(3000570) Elastase.pancreatic [Mass/mass] in Stool

117

648

1.84

8.65

1.3

1.4

ug/g

296.8

283.0

0.32

410

(40760888) Immunoglobulin light chains.free panel - Serum

115

636

1.84

8.55

4.3

1.5

—

(3010421) pH of Blood

112

615

1.86

8.51

5.2

4.2

7.4

0.20

514

(4281824)

105

3.07

7.85

1.1

—

(3037121) Protein [Mass/volume] in Urine

130

771

1.72

7.66

3.5

2.4

g/l

0.3

0.13

247

(3012501) Base excess in Blood by calculation

527

1.87

7.66

5.2

4.3

mmol/l

2.4

2.8

0.56

353

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

130

773

1.71

7.59

2.8

2.9

—

(3022217) INR in Platelet poor plasma by Coagulation assay

506

3995

1.32

7.18

39.2

31.2

inr

1.5

0.24

534

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

106

606

1.78

7.12

2.0

1.5

g/l

1.1

1.2

1.03

100

568

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

163

2.54

7.09

1.3

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

101

572

1.79

7.01

1.8

1.6

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

361

2719

1.38

6.98

3.2

ng/l

267.4

235.7

0.56

335

2506

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

962

8264

1.25

6.95

2.3

2.2

u/l

192.3

235.6

0.79

896

7688

(3019309) Folate [Moles/volume] in Red Blood Cells

709

5900

1.27

6.69

1.9

1.8

nmol/l

1192.2

1162.7

0.33

532

4395

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

3.31

6.69

2.3

1.5

e6/l

536.8

800.8

—

(3016750) Collection duration of Urine

150

2.55

6.69

2.9

1.9

min

495.9

498.2

0.06

107

(3000093) Morphology [Interpretation] in Blood Narrative

240

2.19

6.48

1.2

1.1

—

(3021901) Oxygen saturation in Capillary blood

506

1.80

6.43

3.1

2.6

—

(3042631) Mycobacterium sp identified in Specimen

288

2.07

6.38

2.7

3.0

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

320

2399

1.38

6.36

6.6

6.4

g/l

117.2

121.1

2.74

308

2309

(3048689) Calprotectin [Mass/mass] in Stool

296

2193

1.39

6.32

2.2

1.9

ug/g

152.5

173.1

0.30

230

1678

(40767503) Oxygen content in Capillary blood by calculation

540

1.77

6.26

3.1

2.4

15.6

16.1

0.67

298

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

184

1251

1.50

6.21

8.2

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

115

2.71

6.18

1.4

1.3

—

(3004775) Volume in Urine collected for unspecified duration

220

2.20

6.10

2.9

2.3

682.1

611.7

0.63

135

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

116

2.69

6.08

1.4

1.3

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

215

1516

1.45

6.05

1.5

—

(3028626) Oxygen [Partial pressure] in Capillary blood

583

1.72

6.05

3.2

2.7

kpa

8.0

7.8

0.87

538

(3048879) Bone marrow aspiration report

3.47

6.00

1.5

1.1

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

107

648

1.68

5.91

1.5

1.4

—

16.0

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

100

595

1.71

5.90

2.2

1.5

g/l

0.2

0.92

563

(3017354) Segmented neutrophils/100 leukocytes in Blood

192

2.26

5.83

5.7

2.9

54.6

59.8

0.44

122

(3008757) Leukocyte morphology finding [Identifier] in Blood

205

2.21

5.82

7.5

3.3

—

(44790049)

225

2.15

5.79

2.1

1.4

—

(44790048)

225

2.15

5.79

2.1

1.4

—

(44806118)

225

2.15

5.79

2.1

1.4

—

(44790047)

225

2.15

5.79

2.1

1.4

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

11.15

5.79

1.1

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

103

622

1.68

5.76

2.5

2.2

g/l

122.4

129.2

1.66

472

(40765096) Chromosome analysis panel by Banding

4.39

5.76

1.3

1.1

—

(3025130) Human papilloma virus identified in Specimen

126

2.56

5.70

1.7

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

143

940

1.55

5.67

2.1

2.2

ug/l

299.2

817.5

1.52

136

885

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

201

2.21

5.66

1.1

1.2

u/l

51.7

59.1

0.37

136

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

3.71

5.64

1.1

1.3

ug/l

417.4

51.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

208

2.18

5.63

1.1

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

139

2.46

5.61

1.4

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

203

1439

1.44

5.57

2.5

—

(3009508) Creatinine [Moles/volume] in Urine

945

8255

1.22

5.53

3.8

3.1

mmol/l

6.5

7.0

3.91

798

6812

(3016502) Oxygen saturation in Arterial blood

343

2655

1.33

5.53

6.3

6.0

95.7

95.0

1.42

331

2537

(3015235) Bicarbonate [Moles/volume] in Capillary blood

112

700

1.62

5.50

3.4

3.0

mmol/l

24.8

25.0

0.23

616

(3041096) Erythrocytes [Presence] in Urine by Automated

683

5773

1.24

5.48

4.9

3.7

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

156

1056

1.51

5.41

1.9

1.6

u/ml

8.8

18.8

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

294

2232

1.35

5.40

1.4

1.3

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

115

728

1.60

5.37

1.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

404

1.80

5.24

7.9

3.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

+∞

5.21

1.2

0.0

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.24

5.17

3.2

1.3

—

(3007566) Smooth muscle Ab [Titer] in Serum

508

1.69

4.99

1.3

1.1

titre

81.0

92.0

—

(3024471) HLA-A [Type]

3.90

4.98

1.2

1.0

—

(1761868) Lipid panel - Serum or Plasma

714

6121

1.22

4.95

3.7

3.4

—

(3012516) Albumin [Mass/volume] in Urine

926

8147

1.20

4.91

3.9

3.2

mg/l

215.3

258.7

0.17

628

5084

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

4.08

4.89

13.4

11.3

mmol/l

8.6

5.0

0.62

(3020682) Albumin/Creatinine [Ratio] in Urine

976

8637

1.20

4.84

4.8

4.0

mg/mmol

11.3

8.4

1.13

651

5372

(1616796) Gas panel - Central venous blood

545

1.65

4.78

5.1

3.7

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

176

2.17

4.78

1.6

1.4

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

2.75

4.77

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

185

2.12

4.63

2.7

1.3

—

(3045414) Leukocytes [Presence] in Urine

150

1042

1.46

4.62

2.1

1.9

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

437

3575

1.26

4.62

1.4

1.3

iu/ml

45.9

41.6

0.18

124

1103

(3021788) Differential panel - Synovial fluid

452

1.70

4.57

1.3

1.4

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

242

1831

1.35

4.56

2.8

2.3

ml/min/173m2

57.0

60.0

0.64

123

763

(4010399)

229

1718

1.36

4.56

1.6

1.4

—

(3013512) EKG study

860

7565

1.20

4.49

4.8

4.5

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

278

1.89

4.46

1.6

1.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

243

1.95

4.45

1.4

1.3

u/l

10.1

10.5

0.08

198

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

323

1.81

4.38

1.6

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

338

1.79

4.37

1.2

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

280

1.87

4.37

1.2

1.1

—

(3024932) HLA-DR beta [Type]

3.73

4.36

1.3

1.1

—

(3008536) Aspergillus sp Ab [Presence] in Serum

4.56

4.30

1.6

1.5

—

(3045424) Erythrocytes [Presence] in Urine

365

1.74

4.19

1.7

1.5

—

(3036525) Urea [Moles/time] in 24 hour Urine

6.94

4.16

4.9

3.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

4.36

4.09

1.0

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

272

3437

0.77

4.08

9.9

7.8

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

226

1726

1.34

4.03

3.5

3.1

g/l

125.3

129.1

1.75

219

1673

(3033799) Differential panel - Peritoneal fluid

3.14

3.93

1.8

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.73

3.92

3.1

2.8

—

(3044941) Cell count panel - Synovial fluid

419

1.66

3.89

1.4

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

2.97

3.84

4.2

2.4

u/ml

157469.7

169026.9

—

(3025941) Bacteria identified in Stool by Culture

157

1142

1.40

3.82

1.3

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

6.02

3.81

8.3

1.3

—

(3035880) pH of Pleural fluid

120

2.26

3.80

1.3

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

2.54

3.79

3.1

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

2.54

3.79

3.1

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

2.54

3.79

3.1

1.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

2.54

3.79

3.1

1.2

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

201

1.95

3.77

2.7

1.3

—

(3000475) Leukocytes [#/volume] in Synovial fluid

653

1.52

3.76

1.6

1.5

e6/l

11605.1

14881.9

0.48

472

(3021162) Amylase [Enzymatic activity/volume] in Specimen

12.02

3.76

2.3

3.2

u/l

47.0

861.0

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

2.65

3.73

1.7

2.2

39.4

42.1

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

408

3393

1.24

3.72

1.3

1.2

u/ml

13.3

16.1

0.25

128

1208

(3035637) Corticotropin [Mass/volume] in Plasma

161

2.06

3.71

1.5

1.4

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

583

1.54

3.70

1.7

1.6

iu/ml

0.0

4.6

0.51

136

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

2.80

3.68

3.7

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

2.70

3.65

4.7

2.5

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

162

2.05

3.65

2.6

1.2

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

162

2.05

3.65

2.6

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

162

2.05

3.65

2.6

1.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

276

2198

1.28

3.65

1.4

1.3

—

(36660697) Celiac disease serology panel - Serum

204

1560

1.33

3.63

1.2

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

269

1.80

3.61

1.4

1.3

pmol/l

208.6

276.5

1.39

195

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

263

1.80

3.56

1.1

1.0

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

2.66

3.56

1.6

1.5

ug/l

0.3

0.4

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

131

2.15

3.51

1.5

1.8

u/l

1.3

2180.7

—

(40758292) HTLV I+II Ab panel - Serum

10.02

3.49

1.3

1.2

—

(3009343) pH of Capillary blood

206

1591

1.32

3.43

4.5

3.5

7.4

0.27

211

(21494890) Protein electrophoresis panel - 24 hour Urine

237

1.83

3.43

2.3

1.2

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

1123

10276

1.15

3.39

4.7

4.2

ng/l

401.2

91.6

0.41

867

7864

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

107

2.25

3.38

1.8

1.4

g/l

0.9

0.08

107

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

208

1613

1.31

3.37

4.5

3.5

kpa

5.1

5.2

0.24

192

1468

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

3.10

3.37

1.2

1.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

109

762

1.45

3.34

3.3

3.2

nmol/l

0.8

1.03

587

(3009871) Measles virus Ab [Titer] in Serum

3.25

3.34

1.7

1.5

—

(3036603) Volume of Urine

135

2.08

3.27

1.6

1.4

1789.9

1884.9

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

457

1.57

3.23

1.4

1.6

—

(1002224) Polysomnography panel

539

1.52

3.18

1.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

251

1.76

3.16

1.0

1.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

655

1.47

3.15

1.2

1.1

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

209

1.83

3.08

2.9

2.5

—

(42529406) Shigella sp [Presence] in Stool by Culture

659

1.46

3.06

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.59

3.04

3.8

1.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.59

3.04

3.8

1.2

—

(3003181) Sodium [Moles/volume] in Urine

483

1.52

2.97

1.2

1.4

mmol/l

62.7

63.0

0.02

381

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

127

2.06

2.96

1.7

1.4

u/l

18.1

6.7

0.54

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

141

2.00

2.95

1.1

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

141

2.00

2.95

1.1

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

141

2.00

2.95

1.1

1.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

4.72

2.92

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

288

1.68

2.91

1.5

1.7

g/l

0.7

0.9

0.57

219

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

145

1092

1.35

2.91

3.0

pmol/l

4.3

4.4

1.32

128

923

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

650

1.45

2.90

1.2

1.1

—

(3011985) Renin [Units/volume] in Plasma

289

1.67

2.88

1.4

1.3

mu/l

52.8

63.5

0.22

255

(3014148) Varicella zoster virus Ab [Titer] in Serum

136

1.99

2.85

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

143

1.97

2.85

1.1

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

143

1.97

2.85

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

143

1.97

2.85

1.1

1.2

—

(3019150) Specific gravity of Urine by Refractometry

472

5417

0.85

2.81

5.5

4.6

kg/l

1.0

0.11

857

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

102

731

1.41

2.79

1.3

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

194

1533

1.29

2.78

4.5

3.4

mmol/l

1.4

2.1

1.91

152

1102

(3004451) EKG impression Narrative

138

1.97

2.75

1.3

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

2.37

2.72

2.8

1.6

e9/l

0.3

0.2

0.34

(4094501)

594

1.44

2.68

1.1

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

4.01

2.56

1.4

1.1

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

7.15

2.55

3.0

1.4

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

7.15

2.55

2.2

3.1

—

(4034850)

866

0.66

2.52

12.2

10.7

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

240

1.68

2.47

1.1

1.2

u/ml

4.2

2.6

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

4.38

2.47

10.9

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

233

1.68

2.45

1.2

u/ml

2.1

6.6

2.34

107

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

130

1.93

2.45

1.2

1.1

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

123

1.96

2.45

3.7

4.0

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

204

0.39

2.41

1.1

1.0

ng/l

56.4

47.3

—

126

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

204

0.39

2.41

1.1

1.0

ng/l

686.0

651.7

—

120

(40757373) Influenza virus identified in Isolate

2.42

2.37

3.1

1.5

—

(3002619) Bacteria identified in Specimen by Culture

2.62

2.36

1.2

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

429

1.48

2.30

1.2

u/l

28.1

23.2

0.30

374

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

112

1.97

2.30

1.0

1.3

—

(3043410) Blood group antigens tested for on Red Blood Cells

2.38

2.29

2.4

1.7

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

202

0.39

2.28

1.1

1.0

ng/l

398.8

352.3

—

126

(3029075) Extractable nuclear Ab panel - Serum

2.56

2.27

1.1

1.0

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

539

1.42

2.26

1.4

1.2

u/ml

1.9

2.8

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

3.11

2.22

3.8

1.4

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

3.11

2.22

2.4

1.6

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

132

1028

1.30

2.17

1.9

1.7

ug/l

1.9

1.7

0.08

115

871

(3000012) Reticulocyte production index

144

1.81

2.14

2.2

1.4

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

546

1.40

2.12

1.4

1.2

u/ml

4.0

4.6

0.17

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

2.01

2.10

1.1

1.0

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

2.01

2.10

1.1

1.0

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

132

1036

1.29

2.06

2.7

1.8

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

506

0.61

2.06

1.5

1.6

—

(3017704) Immunofixation for Urine

154

1.76

2.04

2.4

1.2

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

111

1.90

2.00

1.1

—

3.4

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

141

1.78

1.96

1.1

1.0

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

453

1.42

1.96

1.4

1.2

u/ml

23.0

7.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

123

964

1.29

1.96

2.3

1.7

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.36

1.95

1.2

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.97

1.93

2.1

1.8

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

266

1.55

1.92

1.1

1.3

iu/l

28.6

32.4

0.33

235

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.57

1.92

1.1

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

660

6025

1.12

1.89

1.8

1.7

pmol/l

452.4

28545320.9

4.32

518

4845

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.16

1.88

1.0

1.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

2.86

1.86

1.8

1.3

—

(3004269) Kappa light chains [Mass/time] in 24 hour Urine

2.86

1.86

5.9

1.6

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

110

859

1.29

1.82

1.9

1.8

u/l

37.7

38.5

0.11

713

(3006922) Hepatitis E virus Ab [Presence] in Serum

101

1.89

1.80

1.1

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

271

1.52

1.79

1.2

1.3

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

174

1438

1.22

1.78

4.7

3.0

mmol/l

25.1

25.3

0.39

169

1389

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

420

1.41

1.78

1.5

1.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

146

1.72

1.77

1.4

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

151

1231

1.24

1.76

1.3

au/ml

71.0

53.3

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

224

1.57

1.76

1.2

1.1

u/ml

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

105

822

1.29

1.72

1.3

1.2

u/ml

0.2

1.0

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

3.85

1.71

1.4

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

2.30

1.70

1.1

—

(3019225) pH of Specimen

293

2553

1.16

1.68

6.4

3.7

—

(3022313) Gas panel - Capillary blood

137

1113

1.24

1.66

5.0

3.7

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

3.16

1.66

1.0

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

165

1.64

1.1

90.3

91.7

0.12

155

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

167

1.62

1.58

1.2

1.1

—

(3047189) Immunofixation for 24 hour Urine

1.82

1.57

2.9

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

313

1.44

1.57

1.5

70.0

65.3

0.39

203

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

1.85

1.56

1.2

1.1

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

122

1.73

1.54

1.6

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

122

1.73

1.54

1.6

1.2

—

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

2.86

1.50

1.2

1.0

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

115

929

1.25

1.50

1.0

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

163

1369

1.20

1.47

2.4

au/ml

37.8

29.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

268

1.46

1.9

1.3

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

2.50

1.45

2.4

2.5

—

(3017732) Neutrophils [#/volume] in Blood

169

1426

1.20

1.45

2.7

3.2

e9/l

3.6

4.2

3.44

115

994

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

277

1.45

1.44

1.9

1.3

—

(3029937) Albumin [Presence] in Urine by Test strip

684

6346

1.10

1.44

5.5

4.5

estimate

0.0

0.50

294

1888

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

269

1.46

1.44

1.7

1.8

u/ml

14.3

24.7

—

(4212803)

3.13

1.44

1.0

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

270

1.45

1.42

1.9

1.3

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

197

1689

1.18

1.42

1.6

1.5

1.6

0.23

158

1399

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

221

1.50

1.41

1.1

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

175

1486

1.19

1.41

1.2

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

687

1.27

1.39

2.5

1.8

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

182

1.54

1.37

1.4

g/l

0.5

0.4

0.54

129

(3027135) IgG subclass 1 [Mass/volume] in Serum

182

1.54

1.37

1.4

g/l

6.5

7.0

0.21

130

(4062490)

182

1.54

1.37

1.3

1.4

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

182

1.54

1.37

1.4

g/l

2.3

2.9

1.31

128

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1.80

1.37

1.4

1.3

nmol/l

0.2

0.3

1.32

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

700

1.27

1.33

3.3

2.2

ug/min

89.9

91.7

0.02

397

(4133840)

2.15

1.33

1.2

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

1.92

1.33

1.2

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

274

1.43

1.33

1.9

1.3

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

113

1.69

1.31

1.1

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

259

1.43

1.29

1.2

1.3

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.36

1.29

2.1

1.3

—

(4268621)

161

1.56

1.28

2.0

2.2

—

(3025549) Creatine [Moles/time] in 24 hour Urine

2.78

1.28

1.8

1.6

—

(3020650) Glucose [Presence] in Urine

2.09

1.27

1.7

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

269

1.42

1.25

1.9

1.3

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

269

1.42

1.25

1.9

1.3

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.40

1.24

1.7

2.5

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

102

835

1.23

1.22

1.2

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

132

1.60

1.20

2.0

1.6

umol/l

15.2

14.2

0.28

117

(3023419) Bacteria identified in Sputum by Culture

332

1.36

1.19

3.3

2.4

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

2.31

1.18

1.5

2.4

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

1.75

1.12

1.3

1.4

—

1.4

—

(4306422)

217

1.43

1.11

1.2

—

(3028433) Virus identified in Specimen by Culture

1.78

1.10

1.8

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

2.26

1.10

1.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

656

1.24

1.10

1.7

1.4

—

(3014891) Appearance of Pleural fluid

2.19

1.08

1.3

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

327

0.67

1.08

3.5

4.0

umol/l

306.6

343.5

0.79

272

(3044007) Cell count panel - Peritoneal fluid

1.96

1.03

1.6

2.3

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

2.27

1.03

1.0

1.6

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

519

1.26

1.01

2.2

2.0

mg/l

12.7

12.3

0.13

469

(3014051) Protein [Presence] in Urine by Test strip

573

1.25

1.01

2.5

2.2

—

(3016018) Differential panel - Cerebral spinal fluid

188

1.44

1.01

1.1

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

156

1.48

0.98

1.3

—

(3005322) IgE [Units/volume] in Serum or Plasma

129

1108

1.17

0.98

1.3

1.2

u/ml

476.7

262.3

0.54

121

1012

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.97

0.0

1.0

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

128

1100

1.17

0.97

1.2

iu/ml

119.3

120.7

0.02

406

(3018133) Calcium [Moles/volume] in Urine

0.00

0.96

0.0

1.7

—

3.6

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

318

0.69

0.96

1.2

1.1

iu/ml

1.0

798.6

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.89

0.94

1.1

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.89

0.94

1.3

1.6

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

125

1.52

0.94

2.4

1.4

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

924

8830

1.07

0.93

5.4

4.4

—

(3016330) Potassium [Moles/time] in 24 hour Urine

2.15

0.91

1.0

1.2

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.67

0.91

1.0

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

159

1.45

0.91

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

110

1.55

0.90

1.2

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

110

1.55

0.90

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

301

2751

1.11

0.90

2.4

2.5

ug/l

5.9

7.2

1.06

264

2332

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

262

1.34

0.89

1.2

1.3

nmol/l

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

394

1.27

0.89

3.2

2.2

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

1.86

0.87

1.6

1.5

u/l

43.9

54.4

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

204

1.38

0.85

1.2

1.1

—

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

514

1.23

0.85

1.2

—

288.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.78

0.84

1.1

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

1.78

0.84

1.5

—

(3044927) Protein electrophoresis panel - Urine

336

1.28

0.83

1.5

1.2

—

(3024263) Appearance of Synovial fluid

154

1.43

0.83

1.5

1.6

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.70

0.80

1.9

1.5

ng/l

149.4

125.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

156

1.41

0.78

2.8

2.6

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.76

0.0

1.0

—

(4198724)

0.00

0.76

0.0

1.4

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

235

1.32

0.75

1.1

—

21.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

1.64

0.75

1.5

1.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.09

0.74

1.0

1.4

umol/l

84.2

48.1

—

(3015183) Erythrocyte sedimentation rate

1.61

0.72

1.0

1.3

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

211

1.33

0.72

1.4

1.3

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

292

3153

0.92

0.71

5.0

35.1

33.9

1.10

209

1998

(3032773) Endomysium IgG Ab [Titer] in Serum

151

1.39

0.71

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

126

1.43

0.70

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

1.53

0.69

1.1

1.2

ratio

1.1

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

639

1.18

0.69

1.7

1.6

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

258

1.28

0.67

1.5

1.3

e6/l

231676.3

174826.7

0.14

182

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.55

0.67

1.4

1.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

128

1.41

0.65

1.1

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

504

1.19

0.65

1.7

1.3

—

(3035933) Granulocytes/100 leukocytes in Blood

1.73

0.64

1.0

1.5

—

(3026389) Candida sp identified in Specimen by Organism specific culture

288

1.25

0.62

1.2

1.4

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

1.59

0.61

1.8

1.3

pmol/l

18.4

16.0

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.67

0.61

1.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

113

1.42

0.61

2.8

2.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.0

—

(3014271) Vancomycin [Susceptibility]

174

1.32

0.60

2.8

3.1

—

(3006270) Folate [Moles/volume] in Blood

263

1.26

0.59

1.1

1.2

nmol/l

336.0

325.5

0.09

211

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.58

0.0

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.00

0.58

0.0

2.0

—

17.9

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.58

0.0

1.1

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

1.51

0.58

4.4

3.0

—

(3034426) Prothrombin time (PT)

1.51

0.58

1.0

1.3

—

(4024509)

273

1.25

0.58

1.7

1.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

123

1.38

0.57

1.1

1.8

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

1.72

0.57

1.2

1.3

nmol/l

5.6

6.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

521

1.17

0.57

2.8

1.7

mg/l

2.6

4.0

0.61

383

(4146454)

320

0.78

0.57

3.1

2.7

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

283

1.24

0.56

1.5

1.7

mu/l

325.6

306.4

0.18

256

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

1.51

0.56

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

321

1.22

0.54

1.2

1.1

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

432

1.18

0.53

1.2

1.1

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

1.54

0.53

4.0

2.5

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

143

1.33

0.52

2.3

2.1

ug/min

78.8

110.1

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

161

1.31

0.51

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

575

0.85

0.51

4.2

3.8

mg/l

26.2

28.7

0.19

390

(3008152) Bicarbonate [Moles/volume] in Arterial blood

164

1781

0.92

0.50

5.8

6.3

mmol/l

24.0

24.6

1.30

151

1659

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

566

1.15

0.50

1.6

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

107

0.65

0.48

1.0

1.1

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

172

1.28

0.48

1.0

1.1

u/ml

0.4

1.6

0.83

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

1.45

0.48

1.0

1.6

—

(3047181) Lactate [Moles/volume] in Blood

813

0.88

0.46

4.8

5.4

mmol/l

1.3

0.25

720

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

228

1.23

0.45

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

329

1.19

0.45

1.4

1.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

413

1.17

0.44

1.4

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

121

1.32

0.44

1.3

nmol/l

1.0

1.1

0.26

(3006442) Creatine [Moles/volume] in Serum or Plasma

152

0.72

0.44

1.7

1.8

—

66.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

238

1.22

0.44

1.1

miu/ml

196.6

220.2

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.61

0.43

1.0

—

(3018572) Chloride [Moles/volume] in Blood

575

0.87

0.43

5.7

6.0

mmol/l

104.5

104.9

0.28

520

(3039000) Anion gap in Blood

575

0.87

0.43

5.7

6.0

mmol/l

11.6

11.2

0.37

520

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.41

0.0

1.5

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

0.00

0.41

0.0

1.6

—

23.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

445

1.15

0.40

1.9

1.8

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

0.00

0.40

0.0

1.1

—

(3006462) Nitrate [Presence] in Urine

114

1.32

0.40

2.7

3.6

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

(3027944) Amphetamines [Presence] in Urine

171

0.76

0.39

2.0

1.3

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

105

0.67

0.39

1.3

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

1.39

0.38

2.8

1.5

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.32

0.37

1.1

miu/ml

2134.6

1693.0

—

(3000330) Specific gravity of Urine by Test strip

157

1466

1.08

0.37

5.0

3.7

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

107

1.31

0.37

1.2

1.4

—

(3019060) Gas panel - Arterial blood

193

1819

1.07

0.35

3.7

4.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.64

0.35

2.0

1.5

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

108

1.30

0.35

1.0

1.1

u/ml

0.7

1.4

—

(4211845)

126

1.27

0.35

2.6

3.4

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.40

0.35

1.0

1.3

—

36.6

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

225

2133

1.06

0.35

1.7

1.6

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

1.32

0.33

1.3

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

453

1.13

0.33

3.1

1.4

nmol/l

0.8

0.22

366

(21494755) Public health laboratory ask at order entry panel

708

0.90

0.33

1.4

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

322

1.15

0.32

2.1

2.2

mg/l

28.5

24.9

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

128

1.25

0.32

1.0

1.1

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

768

0.91

0.31

1.5

1.3

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

202

1.19

0.31

1.2

1.3

—

(3043409) Potassium [Moles/volume] in Arterial blood

861

0.92

0.31

3.9

4.0

mmol/l

3.8

3.9

0.39

803

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

229

0.83

0.30

1.2

mmol/l

8.5

8.0

0.28

147

(3023410) Appearance of Cerebral spinal fluid

175

1.20

0.30

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.29

0.30

1.1

—

(3028300) Cannabinoids [Presence] in Urine

174

0.80

0.29

1.9

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

297

1.15

0.29

1.2

1.0

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

241

1.16

0.29

1.6

1.4

21.8

26.5

0.38

164

(3027008) Opiates [Presence] in Urine

173

0.81

0.28

1.9

1.3

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

251

1.16

0.28

1.4

1.6

—

(3008898) HLA-B27 [Presence]

469

1.11

0.28

1.2

1.1

—

(3032057) Clostridioides difficile [Presence] in Stool

1.29

0.28

1.8

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

1.27

0.27

1.3

1.4

ug/l

7.6

9.2

—

(3045716) Anion gap in Serum or Plasma

150

0.80

0.27

1.4

1.9

mmol/l

7.3

9.6

1.93

118

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

423

1.11

0.27

1.3

—

(3000764) Benzodiazepines [Presence] in Urine

171

0.82

0.26

1.9

1.3

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.70

0.26

1.6

1.4

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.70

0.26

1.6

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.70

0.26

1.6

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.70

0.26

1.6

1.4

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.22

0.25

1.0

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

1.18

0.24

10.9

1.8

ug/l

11.8

470.5

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

142

1.20

0.24

1.1

1.2

mmol/l

13.3

11.7

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.74

0.24

1.3

1.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

910

1.07

0.24

1.8

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

1.28

0.23

1.0

1.2

—

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

232

0.86

0.22

2.0

2.3

u/field

1.2

2.0

—

(40761535) Cells panel - Urine sediment

217

2254

0.96

0.22

4.9

3.6

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

107

1.22

0.21

1.2

1.3

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.21

0.0

1.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3040893) Potassium [Moles/volume] in Capillary blood

0.00

0.21

0.0

2.4

—

4.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

154

1.17

0.21

1.1

1.2

mmol/l

1.9

2.1

1.77

145

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

1.24

0.21

9.2

4.5

u/ml

40.0

76.0

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

100

946

1.06

0.20

5.7

3.9

mmol/l

24.5

24.9

0.63

848

(3004616) Nuclear Ab [Presence] in Serum

282

0.89

0.20

1.2

—

(3020618) Glucose [Moles/volume] in Synovial fluid

0.00

0.20

0.0

1.1

—

7.3

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.25

0.20

1.2

1.4

—

(3000285) Sodium [Moles/volume] in Blood

1.20

0.19

1.0

1.2

—

(3016879) Cocaine [Presence] in Urine

165

0.85

0.19

1.8

1.3

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

1.13

0.18

1.2

1.5

38.8

26.7

—

(3000034) Microalbumin [Mass/volume] in Urine

251

1.12

0.18

3.5

2.9

mg/l

89.9

24.9

0.62

189

(3040151) Glucose [Moles/volume] in Capillary blood

328

1.10

0.18

3.8

8.8

mmol/l

6.4

7.5

2.41

272

(3051101) Glucose [Moles/volume] in Cord blood

1.21

0.18

2.1

6.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

1.19

0.18

1.0

1.1

103.4

90.9

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

101

1.19

0.16

1.0

1.1

u/ml

1.5

2.4

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

1.14

0.16

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

1.14

0.16

1.0

—

(3022689) Creatine [Moles/volume] in Urine

1.14

0.16

2.4

1.4

—

(3013637) Mi-2 Ab [Presence] in Serum

1.14

0.16

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

1.14

0.16

1.0

—

(3019977) pH of Arterial blood

158

1.14

0.16

2.4

2.2

7.4

—

(3051593) INR in Capillary blood by Coagulation assay

171

0.88

0.14

11.8

13.6

—

(4015189)

1.08

0.14

1.6

2.4

—

(3006653) Thiamine [Moles/volume] in Blood

106

0.85

0.13

1.1

1.2

nmol/l

102.9

146.2

—

106

(44813793)

108

0.83

0.13

1.0

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

109

0.83

0.13

1.2

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

324

0.93

0.12

1.4

1.5

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

200

1.10

0.12

1.2

1.5

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

137

0.88

0.12

1.7

1.4

—

(3017569) Oxygen content in Arterial blood

168

0.89

0.11

2.8

1.8

—

(3024869) Neuronal Ab [Presence] in Serum

1.09

0.09

1.0

1.1

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

145

1.10

0.09

1.2

u/ml

0.4

1.6

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

1.09

0.09

1.0

1.1

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.09

0.09

1.0

1.1

—

(3011288) Drugs identified in Urine by Screen method

107

1.12

0.08

2.4

1.6

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.82

0.08

1.2

1.5

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

287

0.94

0.08

1.9

1.5

—

(1761482) Bacteria [#/volume] in Urine by Culture

796

1.03

0.08

6.1

4.5

—

(3020891) Body temperature

114

1113

1.03

0.07

4.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.81

0.07

1.2

1.6

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

147

1.09

0.07

2.7

2.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.85

0.07

2.0

2.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.85

0.07

2.0

2.5

—

(3037556) Urate [Mass/volume] in Serum or Plasma

1.07

0.07

1.7

1.3

—

(4027681)

1.03

0.07

1.3

1.2

—

(3044242) Glucose [Moles/volume] in Arterial blood

168

1.07

0.06

2.4

1.6

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.11

0.05

1.0

1.2

—

(3005570) Glucose [Moles/volume] in Urine

267

1.05

0.05

1.9

2.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

120

0.92

0.05

1.6

1.8

nmol/l

15.1

15.7

0.10

100

(3008401) Mugwort IgE Ab [Units/volume] in Serum

150

0.93

0.04

1.1

u/ml

1.4

1.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

160

0.94

0.04

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

139

0.93

0.03

1.8

1.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

280

0.96

0.03

1.8

1.7

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

610

1.02

0.02

1.5

1.4

—

(3010838) Calcium [Moles/time] in 24 hour Urine

123

1.06

0.01

1.5

1.8

—

10.2

—

(3044290) Cell count panel - Cerebral spinal fluid

393

1.02

0.01

1.2

—

(3020491) Glucose [Moles/volume] in Blood

174

1.03

0.00

1.3

2.7

mmol/l

7.1

6.9

0.20

119

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

445

0.99

0.00

1.9

1.8

iu/l

3.5

4.7

0.59

147

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

106

1.04

0.00

1.3

1.1

—

(44806420)

106

1.04

0.00

2.0

2.2

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

1.02

0.00

2.7

4.8

13.4

—

(3022621) pH of Urine by Test strip

170

1704

1.00

0.00

3.1

3.4

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

442

1.00

0.00

1.2

e6/l

13.3

27.3

0.45

351

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

442

1.00

0.00

1.4

1.3

e6/l

1015.2

850.5

0.08

370

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

118

1183

1.00

0.00

4.5

4.3

1.5

1.6

0.38

111

1117

(3007930) Methemoglobin/Hemoglobin.total in Blood

117

1167

1.00

0.00

4.4

4.3

0.8

0.9

0.34

109

1102

(3034274) Bile acid [Moles/volume] in Serum --fasting

113

0.97

0.00

1.3

1.4

umol/l

9.6

7.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.0

1.0

—

(3017509) Phencyclidine [Presence] in Urine

0.00

0.0

1.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

0.00

0.0

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

0.00

0.0

2.0

—

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3052592) Norovirus Ag [Presence] in Stool

1.02

0.00

1.3

1.4

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

0.00

0.0

1.6

—

5.6

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

1.2

—

1.0

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

0.96

0.00

1.0

1.1

ng/l

—

102.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

0.00

0.0

1.0

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

0.91

0.00

1.0

1.1

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.0

1.0

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

229.6

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

0.93

0.00

1.0

1.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.0

9.4

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

0.0

1.0

—

(3027696) Helicobacter pylori Ab [Titer] in Serum

0.00

0.0

1.2

—

1368.0

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

0.00

0.0

1.0

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.6

—

2.7

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

0.0

1.2

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

0.00

0.0

8.0

—

(3028707) Methadone [Presence] in Urine by Screen method

0.95

0.00

2.3

1.4

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

0.00

0.0

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

0.00

0.0

2.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

0.00

0.0

1.4

—

Mortality – FinRegistry

↥

Association

Association between endpoint CD2_INSITU_SKIN_EXALLC and mortality.

Females

Parameter	HR [95% CI]	p-value
CD2_INSITU_SKIN_EXALLC	0.987 [0.88, 1.1]	0.817
Birth year	0.992 [0.98, 1.0]	0.056

During the follow-up period (1.1.1998 — 31.12.2019), 3413 out of 10552 females with CD2_INSITU_SKIN_EXALLC died.

Males

Parameter	HR [95% CI]	p-value
CD2_INSITU_SKIN_EXALLC	1.13 [0.98, 1.3]	0.09
Birth year	0.986 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 2727 out of 7678 males with CD2_INSITU_SKIN_EXALLC died.

Mortality risk

Mortality risk for people of age

years, who have CD2_INSITU_SKIN_EXALLC.

N-year risk	Females	Males
1	0.104%	0.176%
5	0.583%	1.22%
10	1.301%	3.321%
15	2.481%	6.212%
20	4.533%	10.461%

Relationships between endpoints

↥

Index endpoint: CD2_INSITU_SKIN_EXALLC – Carcinoma in situ of skin

GWS hits: 5

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Carcinoma in situ of skin

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints